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INFORMATION TECHNOLOGY MEETS HEALTHCARE:
THE PRESENT AND FUTURE OF GERMAN AND EUROPEAN
E-HEALTH INITIATIVES
Klaus M Brisch, LL.M * and Claudia E. Haupt**
INTRODUCTION
A recent Boston Globe Op-Ed aptly summed up the basic concept of e-
health, stating that "these technologies let computers do what they do
best -- collect and disseminate data -- while letting doctors do the
doctoring."' As in the United States, the future of healthcare is a highly
important current issue both in Germany and throughout the entire
European Union (EU). Information technology is seen as a tool to bring
about the improvement of processes and a reduction of costs.
Consequently, the EU and Germany are advancing a host of e-health
initiatives. On the EU level, the Commission has set its e-health agenda
in an action plan it plans to implement by 2010. The initiatives envision
better access to care and, simultaneously, a higher quality and lower
costs of care. In a largely un-harmonized market due to the principle of
subsidiarity, 2 these initiatives are bound to conflict with national
legislation. Nevertheless, the Commission stresses that even though
Member States are primarily responsible for healthcare, they have to
comply with community law.
3
In Germany, structural changes envisioned to strengthen
healthcare modernization and, along with it, e-health initiatives found
their way into national legislation, most notably the Public Health
Insurance Modernization Act (Gesetz zur Modernisierung der
gesetzlichen Krankenversicherung) of 2003.4 In a highly regulated
market, however, new initiatives are bound to meet old barriers. The
future success of e-health initiatives hinges on several parameters. This
article will specifically focus on two spotlight issues, data protection
• Partner, Graf von Westphalen, Cologne, Germany.
** Attorney, Cologne, Germany; LL.M. candidate (2009) The George Washington
University Law School.
1 Joseph B. Martin, Op-Ed., Digital Doctoring, BOSTON GLOBE, March 29, 2007.
2 Treaty Establishing the European Community, art. 5, Feb. 7, 1992, O.J. C 325/42.
[hereinafter EC Treaty].
3 European Commission, Information Society and Media, eHealth Topic of the
Month: Legal Challenges in eHealth, June 2007, at 1, available online at
http://ec.europa.eu/information-society/newsroom/cf/document.cfin?action=display&
doc id=350 (last visited Oct. 30, 2008) [hereinafter Legal Challenges].
4 BUNDESGESETZBLATT TEIL I, NR. 55, S. 2190 (2003).
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and issues concerning electronic signatures. As will be shown, both are
crucial to the success of many e-health components.
The German struggles with the online pharmacy DocMorris
illustrate the interrelationship between national and supranational law
in the area of healthcare in an exemplary fashion. The questions raised
in connection with DocMorris range from interpretations of domestic
law to the application of Community law. In the DocMorris decision of
the European Court of Justice (ECJ), the court was faced with the
question whether the prohibition of the sale of drugs over the internet
conformed to the supranational regulations permitting the free
movement of goods.
In the DocMorris case, the German legislature, in anticipation
of the ruling of the ECJ, implemented far-reaching reforms to its
national legislation. Similarly, EU regulations already apply in the
areas of data protection and the electronic signature. Although the EU
member states remain nominally in charge of their individual national
health policies, they are already significantly influenced by Community
law and, as can be seen from the Commission's action plan, the EU
intends to further implement its Community e-health initiatives.
Part I of this article provides an overview of the European and
German e-health initiatives. As will be shown, the introduction of
information technology in the form of the electronic insurance card and
the electronic medical record as well as the introduction of information
technology-based managed care models are key elements of a current
trial phase. Parts II and III will spotlight the key issues in the area of
data protection and the use of the electronic signature, especially in
connection with the electronic health card. Part IV then turns to the
legal problems raised in connection with online pharmacies, which
culminated in the DocMorris decision of the European Court of Justice
(ECJ).
I. SUPRANATIONAL AND NATIONAL E-HEALTH
INITIATIVES
E-health initiatives are currently ongoing both on the EU and
the German national level. Both are aimed at improving the efficiency
of healthcare while at the same time reducing its costs. The European
Union celebrated its 50 th birthday in 2007, having been originally
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founded in the Rome Treaty in 1957.5 Yet, a supranational public
health policy is a relatively new phenomenon. It was first introduced
into the Maastricht Treaty in 1992 - which contained a provision
encouraging the cooperation of Member States and offering support of
the Community - and became a stronger presence in the 1997
Amsterdam Treaty. 6 Article 152(1) of the EC-Treaty contains the
mandate to ensure a high level of human health protection in the
definition and implementation of all Union policies and activities, with
the Community complementing national policies directed at "public
health, preventing human illness and diseases, and obviating sources of
danger to human health."7 Further, pursuant to Article 152(2), the
Union is called upon to encourage cooperation of and lend support to
Member States in achieving the policy goals. It should be noted that
Article 152(5) itself contains a subsidiarity clause, stating that it does
not interfere with the responsibility of the Member States in the area of
public health.
A. The European Commission's "e-Health Action Plan"
As healthcare systems worldwide are faced with major
challenges, the Union is engaged in an effort to address the challenges
most pertinent in its Member States. The rising demand for health and
social services in the EU is largely due to a changing demographic
structure of the Union's population. According to projections, "by 2051
close to 40% of the Union's population will be over 65 years old.",8 At
the same time, both patients and health professionals are increasingly
mobile within the internal EU market. Moreover, expectations of
citizens as to the quality of care are on the rise, and from the
perspective of the state actors, a reduction regarding access inequalities
is sought. Managing the vast amounts of health information is a
challenge; while at the same time, it is intended that the health
information be available securely, and quickly accessible when needed
in order to be processed efficiently. Complex organizational changes
5 Treaty Establishing the European Economic Community, Mar. 25, 1957, 298
U.N.T.S. 11.
6 Legal Challenges, supra note 3, at 1.
7 EC Treaty supra note 2, art. 152(1).
8 COMMISSION OF THE EUROPEAN COMMUNITIES, COMMUNICATION FROM THE
COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN
ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS, eHealth-
making healthcare better for European e-Health Area, at 5, Brussels, Apr. 30, 2004,
COM(2004) 356 [hereinafter: e-Health Action Plan].
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are needed in order to match and utilize the potential of the increasing
pace of technological advances while ensuring availability of best
possible healthcare under budgetary constraints. 9 On the European
level, the focus on e-health is part of a larger effort in the area of
community public health. The Commission has proposed further
support of the Member States in their individual efforts in reforming
national healthcare systems.
10
In 2007, the EU-Commissioner for Information Society and
Media, Viviane Reding, stated that the e-health sector is growing faster
than many other areas, including the pharmaceutical or drug sectors.
11
The European Commission anticipates that by 2010, e-Health spending
may comprise up to 5% of the total health budget of the 25 Member
States.12 In 2000, with 15 Member States, the budget amounted to only
1%. European businesses, according to the Commission, have every
opportunity to become leading global players in this new industry.
13
One goal is to support the growing number of national online-services
such as the French "Dossier M6dical Personnel" or the Danish health
portal "Medcom.' 14 Commissioner Reding further emphasized the
importance of data security and trust in the system; consequently, data
protection remains a key aspect in the Commission's initiatives.
Transnational projects are also at the center of attention. The EU
supports a transnational project called "TEN4Health" with health
insurance providers and hospitals in Austria, Belgium, the Czech
Republic and the Netherlands. EU funding for research in the area of
e-health according to Commissioner Reding has been doubled.16
The European Commission has set an ambitious e-health
agenda. The "eEurope 2005" action plan agreed to at the Sevilla
European Council in 2002,17 contained a chapter on e-health.' 8
9 Id. at 4.
'° Id. at6.
11 "Datensicherheit schaffit Vertrauen", BAK intern, Juli 2007, at 7, available online
at http://www.bundesaerztekammer.de/downloads/BAeKINTERNJuli-2007-2.pdf
(last visited Oct. 30, 2008) [hereinafter Reding Interview].
12 e-Health Action Plan, supra note 8, at 10
13 Id.
14 Reding interview, supra note 11. See also e-Health Action Plan, supra note 8, at 10
- 12 (for a description of Medcom as well as the British "NHS Direct Online"
service).
15 Reding Interview, supra note 11.
16id.
17 COMMISSION OF THE EUROPEAN COMMUNITIES, COMMUNICATION FROM THE
COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE ECONOMIC AND
SOCIAL COMMITTIES AND THE COMMITTEE OF THE REGIONS, eEurope 2005: An
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Proposed actions included electronic health cards, health information
networks, and online health services.' 9 In April 2004, the European
Commission adopted an "e-health action plan" entitled "e-Health -
making healthcare better for European citizens: An action plan for a
European e-Health Area." 20 In this action plan, the Commission
outlines a comprehensive program including benchmarks until 2010.
Defining e-health as "the application of information and
communications technologies across the whole range of functions that
affect the health sector," the Commission states that e-health can
improve both access to and quality and effectiveness of health care.2 1
As more than merely internet-based applications, the Commission
envisions e-Health tools or solutions to include products, systems and
services for both health authorities and professionals as well as
personalized health systems for patients and citizens. Examples given
by the Commission include "health information networks, electronic
health records, telemedicine services, personal wearable and portable
communicable systems, health portals, and many other information and
communication technology-based tools assisting prevention, diagnosis,
treatment, health monitoring, and lifestyle management.,' 2 The
Commission expects better care for less money in citizen-centered care
as a result of combining e-health with organizational changes and new
skills, thus responding to the challenges faced by the healthcare sector
today. In fact, the health sector employs 9% of Europe's workforce.23
The Commission views e-Health as a tool for productivity gains
and as "tomorrow's instrument for restructured, citizen-centred health
systems and, at the same time, respecting the diversity of Europe's
multi-cultural, multi-lingual health care traditions. 24  Successful
information Society for All, An action plan to be presented in view of the Sevilla
European Council at 1, Brussels, May 28, 2002, COM(2002)263 available at
http://ec.europa.eu/informationsociety/eeurope/2002/newslibrary/documents/eeuro
pe2005/eeurope2005_en.pdf. (last visited Oct. 30, 2008) [hereinafter eEurope 2005];
ULRIKE BECK, MEDICAL CALL CENTER UND MEDIZINISCHE BERATUNG IM INTERNET -
HAFTUNGSFRAGEN, 137 (2005).
'
8
.eEurope 2005, supra note 17, at 12.
I'9 1d. at 13.
20 e-Health Action Plan, supra note 8. See also EUROPEAN COMMISSION, EUROPE'S
INFORMATION SOCIETY, The Right Prescription for Europe's eHealth, May 5, 2008,
http://ec.europa.eu/informationsociety/activities/health/policyaction plan/indexen.
htm (last visited Oct. 30, 2008) (for an overview of the Commission's activities).
21 e-Health Action Plan, supra note 8, at 4.
22 id.
23 Id., at 8.24 Id., at4.
2009]
DEPAUL JOURNAL OF HEALTH CARE LAW
examples of e-Health initiatives cited by the Commission include
"health information networks, electronic health records, telemedicine
services, wearable and portable monitoring systems, and health
portals." 25 According to the Commission's account, in 2004 at least
four of five European doctors had an internet connection and a quarter
of Europeans used the internet for health information. 26 The European
Community has been supportive of e-health research since the early
1990s. 27 Since then, the financial support reached C 500 million, with a
total budget about twice that amount.2 8 Having put much of this
research into practice has made Europe a leader in the use of electronic
health records in primary care and in the use of electronic health card.29
The Commission attributes the e-health industry, with a turnover of C
11 billion, the potential to become the third largest industry in the
health sector, and by 2010, it estimates that the e-health industry may
account for 5% of the total health budget although at present, it still
mainly consists of small- and medium enterprises in need of a more
favourable business environment.
30
The Member States, according to the Commission, have sought
to combine the best practices and experience from throughout the EU,
thus showing their dedication to moving along the e-Health agenda.31
The Commission's plan of creating a "European e-Health Area" would
build on a variety of common policies and initiatives and create
concerted efforts providing an environment fostering the integration of
32
related policies on the Community level. The Commission concludes
that a European e-Health Area will provide a useful framework for
exchanging best practices and experience, allowing for the
development of common approaches. The action plan intends to ensure
that by 2010, the EU "will be well placed to measure the impact of e-
Health in terms of better access and better, more efficient, services as
well as on the overall productivity of the healthcare sector., 33 It is the
Commission's vision to make e-Health common for health
professionals, patients and citizens and to ensure adequate funding.
34
25 Id.
26 Id
27 Id.
28 id.
29 Id.
30 Id.
31lid.
32 Id.
33 Id., at 22.
34 Id., at 23.
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In order to realize these objectives, the Commission created a
timetable for the implementation of the goals set forth in the action
plan.35 The implementation is grouped under three headings: common
challenges, pilot actions, and working together and monitoring
practices. 36 The objectives of the first group include the development of
a European Health Insurance Card 37 (which was introduced in 2004) as
well as, for example, support of e-health services based on fixed and
wireless broadband and mobile infrastructures (2004-2008)38, providing
a framework for greater certainty of products and services within the
existing products liability legislation (until 2009) 39 . The second group
envisions, among others, the creation of a European Union health portal
providing access to EU public health information (Health-EU, online at
http://ec.europa.eu/health-eu/). 40 By the end of 2008 it expects member
states to provide online services such as teleconsults, e-prescription, e-
referrer, telemonitoring and telecare.4 1 The third group is concerned
with facilitating the dissemination and exchange of information, at
conferences and through publication of studies.42
B. German e-Health Initiatives and the National Legal Framework
German public (statutory) health insurance law is a part of the
German social security laws codified in the ten books of the Social
Insurance Code (Sozialgesetzbuch, SGB). The fifth volume, SGB V,
contains the regulations concerning public health insurance. Health
insurance is the oldest of the three classic branches of social insurance -
comprised of health insurance, accident insurance, and pension
insurance - dating back to the law regarding health insurance of
workers of June 15, 1883. 43 Although the German Constitution, the
35 Id at 24-26.
36 Id at 24-25.
37 Id. See also COMMISSION FO THE EUROPEAN COMMUNITIES, COMMUNICATION
FROM THE COMMISSION, concerning the introduction of a European health insurance
card, Brussels, Feb. 17, 2003, COM (2003) 73.
38 eHealth Action Plan, supra note 8, at 25.
39 id.
40id
41 id.
42 Id.,at 26.
43 Karl Peters, Vorbemerkungen zum SGB V, at No. 2 in KASSELER KOMMENTAR
SOZIALVERSICHERUNGSRECHT, VOL. 1 (Klaus Niesel, ed., 53rd Update Edition, 2007).
See also Rainer Hess, Das Recht der privaten und gesetzlichen Krankenversicherung
incl. Vertragsarztrecht, 37, 40-47 in: HANDBUCH DES FACHANWALTS MEDIZINRECHT
(Frank Wenzel, ed., 2007); Ursula Weide, A Comparison of American and German
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Basic Law (Grundgesetz), does not contain any explicit provisions
regarding public health insurance, 44 Article 20 (1) speaks of the social
federal state, codifying the social state principle (Sozialstaatsprinzip).45
Further, it should be noted that the founders of the Basic Law already
knew a more than 60 year old, well-established health insurance
system. The Basic Law thus is interpreted as guaranteeing the existence
46
of such an insurance system.
Rather than being an entity of state health care, the statutory
health insurance is truly an insurance, and it not only concerns illnesses
already incurred but their prevention as well. 4 7 It is a compulsory
public insurance, largely removed from freedom of contract. Consisting
of several individual providers, it does not constitute a uniform
insurance. 48 Unlike tax-based health systems, the German statutory
health insurance limits the obligation to enter into the insurance to a
statutorily defined income-based limit. When this limit is exceeded,
there is no obligation to enter into statutory health insurance (section 6
(1) No. 1 SGB V) but instead a choice between statutory or private
health insurance. 49 There are several significant differences to private
health insurances, which only insure a fraction of the German
population. The premiums of the private insurances for example are
risk-related, and there is no general premium-free insurance of
relatives.5 °
The public (statutory) health insurance is the keystone of the
German health care system, and it is also employed to perform central
control tasks. It further is an important economic factor as numerous
healthcare service providers such as hospitals and pharmacies as well
as individual physicians and dentists are fundamentally dependent on
the public health insurance or, as in the case of the pharmaceuticals
Cost Containment in Health Care: Tort Liability of U.S. Managed Care
Organizations vs. German Health Care Reform Legislation, 13 TUL. EUR. & Civ. L.F.
47, 58-60 (1998) (for historical overviews of the German public health care system).
44 Peters, supra note 43, at No. 16.
45 See Translation: AXEL TSCHENTSCHER, THE BASIC LAW, available online at
http://www.servat.unibe.ch/jurisprudentia/lit/thebasiclaw.pdf (last visited Oct. 30,
2008) (Article 20 states "The Federal Republic of Germany is a democratic and social
federal state.").
46 Peters, supra note 43, at No. 16.
47 Id. at No. 24. See also Weide, supra note 43, at 61 (for an overview of insurance
benefits available under German statutory health insurance).
48 Peters, supra note 43, at No. 24.
49 Hess, supra note 43, at 48.
50 Peters, supra note 43, at 25. See also Hess, supra note 43, at 47(for a systematic
comparison of statutory and private health insurance).
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industry, have an important market in the state health insurance.
Finally, the significance of public health insurance in the overall
economy is illustrated by the fact that the general rates for public health
insurance are a key factor in determining ancillary labor costs.
51
1. Social Insurance Law and Healthcare Modernization
Currently, the German healthcare system is described as largely
split into sectors, with little interaction between the individual parts,
such as physicians in private practice, hospitals, and rehabilitation
facilities. A special feature of the German health system is the strict
separation between ambulant and hospital care. This division has been
identified as burdening the quality of care as improvements are only
made within the respective sectors, but the interfaces between the
sectors are neglected and therefore, trans-sector processes are
uncoordinated. This can result in long waiting periods, repeated
examinations, lack of consistency in treatment, and communication
problems.53 The Associations of Statutory Health Insurance Providers
(Kassendrztliche Vereinigungen, KV) are mandated to ensure medical
care for members of the public (statutory) health insurance as stated in
sections 72 (1), 75 (1) SGB V. To provide for medical care, the KVs
use physicians licensed to provide statutory healthcare services
(Vertragsdrzte).54 Every individual physician has a claim to access to
this system, i.e., to be licensed to provide statutory healthcare services,
unless license restrictions are in place in areas in which the number of
licensed physicians is deemed too high. Access to this market entitles
each physician licensed in the statutory system to treat all insured
individuals of the public health insurances. 55 The Associations of
Statutory Health Insurance Providers and the public health insurance
51 Peters, supra note 43, at 26. See also Till-Christian Hiddemann & Stefan Muckel,
Das Gesetz zur Modernisierung der gesetzlichen Krankenversicherung, 57 NEUE
JURISTISCHE WOCHENSCHRIFT [NJW] 7 (2004)(stating that the employer
contributions to social insurance are seen as a key obstacle to employment growth.)
52 Joachim Kartte, Qualitdtsoptimierung durch Vernetzung im Gesundheitswesen 47,
in EHEALTH 2003 (Gesellschaft fUr Versicherungswissenschaft und -gestaltung e.V.,
eds., 2004).
53 Matthias von Schwanenfltigel, Moderne Versorgungsformen im Gesundheitswesen
-- Fdrderung der Qualitdt und Effizienz, 15 NEUE ZEITSCHRIFT FOR SOZIALR ECHT
[NZS] 285 (2006).
54 Hiddemann & Muckel, supra note 51, at 7; Hess, supra note 43, at 73-74.
55 Hiddemann & Muckel, supra note 51, at 7. See also Hess, supra note 43, at 109-
116 (for details of the licensing process).
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providers close contracts governing the specifics of public health care,
thus engaging in a type of de facto rule-making. All physicians licensed
to provide statutory healthcare services are obliged to enter into these
contracts negotiated and closed by the KV and the insurance
providers.56 This type of collective contract system has been subject to
criticism. First, the legitimacy of de facto rule-making by collectively
entering into contracts has been questioned as a general matter. Second,
the lack of competition and the inability to close individual contracts
has been criticized.57 Several new concepts are envisioned to cut costs
and improve the efficiency of health care at the same time. A primary
goal is overcoming the scattering of individual actors and replacing it
with a network of health care providers. 58 In the area of healthcare
modernization, as will be shown, the federal government and the
legislature envisioned the introduction of information technology to be
a central building block of a new healthcare infrastructure. Before
addressing the role of information technology, however, this section
will first provide an overview of the envisioned new concepts.
There is a growing demand, especially of public health
insurance providers, to develop and implement some type of managed
care systems. The health care costs in Germany are among the highest
in Europe and they are continuously on the rise. 59 In fact, it has been
asserted that the very concept of the social state has entered a critical
phase and the currently high level of social welfare benefits cannot be
financed in the long term. Managed care models frequently referred to
as having been successfully implemented are, for example, approaches
taken in the United States and in Switzerland.61 In the wake of
healthcare modernization, healthcare service providers were given new
opportunities for trans-sector cooperation and interdisciplinary services.
The goal was to increase competition among the service providers. The
formerly more or less strict boundary between ambulant and hospital
56 Hiddemann & Muckel, supra note 51, at 7. See also Hess, supra note 43, at 75-84
(for details on the contractual relationship).
57 Hiddemann & Muckel, supra note 51, at 7.
58 Kartte, supra note 52, at 48.
59 Peter Bach & Stephan Hiitt, Rechtsfragen des Gesundheitsmanagements, No. 85 in
PRIVATE KRANKENVERSICHERUNG (PETER BACH AND HANS MOSER, EDS, 3rd Ed.
2002).
60 Hiddemann & Muckel, supra note 51, at 7.
61 Id; Michael Quaas, Krankenhausrecht, 1113, 1165 in HANDBUCH DES
FACHANWALTS MEDIZINRECHT, supra note 32. See also BECK, supra note 17, at 43-
47(discussing call centers and web portals in Switzerland).
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62care was further eroded. New concepts envisioned by the legislature
were, for example, integrated care concepts, comprehensive medical
care centers (Medizinische Versorgungszentren, MVZ) and disease
management programs (DMP).
Integrated care concepts had been envisioned prior to the latest
health insurance reform and were already codified in the 2000 reform
of the SGB V.63 The goal of integrated medical care is to overcome the
strict separation between hospital care and ambulant care currently in
place in Germany, and to offer a more individualized healthcare
approach.64 Individual healthcare service providers can directly enter
into contractual agreements with each other under sections 140a et seq.
SGB V with the goal of providing comprehensive integrated care of
insured individuals.65 After the reform, individual physicians can enter
into contracts with health insurance providers just as the holding
companies, which themselves of course do not offer medical care. The
body then must offer the contracted services by medical care providers,
such as contracted physicians or hospitals. The advantage of such a
solution would be that the company performs the necessary
management tasks while the service providers focus exclusively on
medical care. 66 The Associations of Statutory Health Insurance
Providers no longer set the framework for treatment in integrated
care. 6 7 Oftentimes, the topic of MVZs is seen in connection with
integrated care concepts, although there is no necessary connection
between the two. The MVZ can be a contractual partner in the
framework of integrated care concepts, and it structurally lends itself to
involvement in integrated care. The topic of disease management
programs (DMP) is also discussed in this context.69
62 Joachim Kasper § 17, No. 1 in MONCHENER ANWALTS HANDBUCH SOZIALRECHT
(Hermann Plagemann, ed, 2nd Edition, ); Rainer Hess Vor § 140a No. 1 SGB V in
KASSELER KOMMENTAR, supra note 43; Hess, supra note 43, at 167.
63 Kasper, supra note 62, at § 17, No. 4; Hiddemann & Muckel, supra note 51, at 8;
von Schwanenfltigel, supra note 53, at 287. See also generally Hess, supra note 43, at
167-170
64 Kasper, supra note 62, at § 17, Rn. 4; Hess, supra note 43; Hiddemann & Muckel,
supra note 51, at 8; von Schwanenfligel, supra note 53, at 287.
65 Kasper, supra note 62, at § 17, No. 4; Hess, supra note, 43; Hiddemann & Muckel,
supra note 5 1, at 8.
66 Hiddemann & Muckel, supra note 51, at 8; von Schwanenflfigel, supra note 53, at
287.
67 Von Schwanenflilgel, supra note 53, at 287-288.
68 Kasper, supra note 62, at § 17, Rn. 6; Hiddemann & Muckel, supra note 51, at 8.
69 Von Schwanenflaigel, supra note 53, at 287 (explaining that integrated care can
include DMPs).
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The idea of the MVZ has been traced to the concept of
Polikliniken in the former German Democratic Republic.7 0 The goal of
the creation of MVZs is providing patients with one-stop-healthcare.
Physicians of different specializations, but also pharmacists and
physical therapists, would be enabled to work in the same space, thus
creating a variety of advantages for patients, such as improved care
management and are more structured exchange of information between
the medical care providers. The repetition of examinations, for
example, would be eliminated. Further, care is to be better coordinated
and waiting times are to be reduced y.7 According to the definition
contained in section 95(1) SGB V, MVZs are interdisciplinary entities
under the direction of physicians in which licensed physicians work
either as employees or as physicians licensed to provide public health
insurance services. 72 The novelty of the concept lies in the assumption
that care by physicians contracted under statutory health insurance is no
longer solely provided by self-employed physicians licensed to provide
statutory healthcare services in private practice and in the collective
contract system described above. 73 Instead, MVZs themselves are
licensed and now act as competitors, which was the legislature's stated
intention.7 4 It has been pointed out that, in practice, not only physicians
but also hospitals and pharmacies are increasingly interested in
participating in MVZs as a way to utilize synergy effects and access the
ambulant care market. 75 MVZs can be founded and run by hospitals,
and set up in immediate proximity. It is legally permissible to employ
hospital physicians part-time at the MVZ and thus to ensure a close
relationship between the MVZ providing ambulant care and the
hospital. In addition to the medical advantages of a closer coordination
between ambulant care and hospital care, management tasks can be
performed by the hospital. y6 This creates another advantage in freeing
70 Kasper, supra note 62, at § 17, Rn. 5; Hiddemann & Muckel, supra note 51, at 9;
von Schwanenfligel, supra note 53, at 289.
71 Von Schwanenfluigel, supra note 53, at 290.
72 Kasper, supra note 62, at § 17, Rn. 5. See also Andr6 Fiedler and Tilmann Weber,
Medizinische Versorgungszentren, 13 NEUE ZEITSCHRIFT FOR SOZIALRECHT [NZS]
358 (2004)(providing a detailed analysis of the legal definition and its problem areas).
73 Kasper, supra note 62, at § 17, Rn. 5; Friedrich E. Schnapp, Konkurrenzschutzfr
niedergelassene A'rzte gegen medizinische Versorgungszentren, 13 NEUE ZEITSCHRIFT
FOR SOZIALRECHT [NZS] 449, 449 (2004).
74 Schnapp, supra note 73 at 449; Hiddemann & Muckel, supra note 51, at 9-10;
Quaas, supra note 51, at 1166-1167.
75 Kasper, supra note 62, at § 17, Rn. 5.
76 Hiddemann & Muckel, supra note 51, at 10.
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physicians from their administrative tasks which, in private practice,
have been found to account for one fifth of the work time of
physicians. 77 The question has been raised, however, whether the law
was designed to give MVZs a competitive advantage over private
practice physicians and whether legislatively awarding this advantage
is, in fact, constitutional.78 While the question has therefore been raised
whether and, if so, how physicians can challenge the creation of
MVZs, 79 others point out that especially for young physicians MVZs
provide an attractive way to enter the job market.8 0
It is claimed that the quality and efficiency of a health care
system can be judged by its treatment of chronically sick individuals.8 '
Disease Management Programs (DMPs) offer a form of disease-
centered management of care problems. They contain interdisciplinary
care tasks and demand the continuous evaluation of service scope and
contents. Economic evaluations are thus a central aspect of DMPs, and
the ultimate goal is the standardization of care, constituting a form of
quality management.8 2 The legal ramifications were instituted in 2002,
allowing for programs in the areas of diabetes, coronary heart disease,
breast cancer and pulmonary disease. 83 The primary goal of DMPs is to
address the risk of insuring chronically sick individuals by treating
chronic illnesses more efficiently and more economically. 84 One of the
key problems regarding chronic illnesses is to find a reasonable level of
77 Von Schwanenflfigel, supra note 53, at 290.
78 Schnapp, supra note 73, at 450 (expressing doubt that the competitive advantage
for MVZs is constitutional and pointing out difficulties in constitutionally challenging
the provisions allowing MVZs).
71 Id. at 450-452.
80 Kasper, supra note 62, at § 17, Rn. 5; von Schwanenfliigel, supra note 53, at 290;
Udo Degener-Hencke, Integration von ambulanter und stationdrer Versorgung -
6ffnung der Krankenhiuser fr die ambulante Versorgung - Rahmenbedingungen
nach dem GKV-Modernisierungsgesetz (GMG), 12 NEUE ZEITSCHRIFT FOR
SOZIALRECHT [NZS] 629, 630 (2003).
81 Von Schwanenfldigel, supra note 53, at 287.82 Jens Ricke, Informationsmanagement in Disease Management Programmen, 105,
105, in EHEALTH: INNOVATIONS- UND WACHSTUMSMOTOR FOR EUROPA (Jbrg
Eberspacher, Arnold Picot, Gtinter Braun, eds., 2006); Hess, supra note 32, at 165-
166. But see, e.g., Gernot Rtiter, Auf der Strecke bleibt die drztliche Ethik, 98
DEUTSCHES ARZTEBLATT A3016 (2001)(criticizing DMPs because they result in a
loss of the patient's control regarding treatment).
83 Ricke, supra note 82, at 107; Thomas Vollm6ller, Rechtsfragen bei der Umsetzung
von Disease-Management-Programmen, 13 NEUE ZEITSCHRIFT FOR SOZIALRECHT
[NZS] 63 (2004); Hess, supra note 32, at 166.
84 Ricke, supra note 82, at 106-107; Vollm6ller, supra note 83, at 63.
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care as chronic illnesses tend to be over-treated or under-treated.
85
DMPs provide two key functions: first, an integration of ambulant and
hospital care, and second, a guiding function in which patients can be
guided in treatment- and care processes. s6 The health insurance
providers themselves are responsible for developing the programs,
which are only broadly permitted by law, without specific detail
87regulations. Generally, all types of contractual relations of the SGB V
are permissible in the framework of DMPs.8 8 However, because of the
nature of public health insurance, procurement, competition, and
antitrust regulations have to be followed. 89 For purposes of this
discussion, one key DMP program type is the institution of Medical
Call Centers and Web Portals, especially in the area of health coaching
programs. The parameters to be monitored are set by the physician and
the implementation of the program and the monitoring is performed by
the patient and the call center.90 These programs are especially sought-
after by health insurances seeking to influence the relationship between
the insured individual and the health care professional before medical
treatment becomes necessary. Exercising influence can take two main
avenues: On the one hand, health insurances are seeking to directly
address the insured individual and thus try to indirectly influence the
relationship with the health care professional. One example would be
medical call centers for medical advice or medical advice information
material. Further, new insurance premium structures are intended to
reward the insured individual if he seeks advice from a general care
provider, such as a family doctor, before consulting a specialist. On the
other hand, there are tendencies to implement new legal relationships
between insurance providers and health care professionals. Examples
would be contracts between insurance providers and individual
hospitals. Quality standards are subject to those agreements. Further
examples would be the support of physician networks or financial
participation in hospitals.91 Thus, DMP relates back to the integrated
care and MVZ models already described.
85 Ricke, supra note 82, at 113.
86 Vollmller, supra note 83, at 64.
87 Id.; Beck, supra note 17, at 31.
88 Vollm6ller, supra note 83, at 64.
89 Id. at 65-66.
90 Beck, supra note 17, at 31.
91 Bach & Htitt, surpa note 59, at No. 85.
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2. Introducing Information Technology
Provisions concerning the development of healthcare are
contained in sections 63 et seq. SGB V. These provisions are the basis
for pilot projects of the state health insurances. By introducing modern
information technology into the healthcare system, the goals are to
improve care and the flow of information, to cut costs, to advance
research and to influence the insured individuals, promoting a healthy
lifestyle. 92 The legislature envisioned a significant improvement with
respect to the innovation capabilities of the healthcare system and the
public health insurance system.93 The primary target area of the pilot
projects are information technology and organizational improvements
of the use of data.94 This includes granting wider competences
regarding the gathering, processing and use of personal data.95 As an
example, the electronic health card (patient chip card) is mentioned in
the legislative materials. 96 Electronic health cards are found to be
important for three different reasons: (1) they constitute important
storage devices for patients' personal health data, (2) they constitute a
test case in which to evaluate the possibilities of interconnection
between different providers, and (3) the electronic health card is
regarded as a prerequisite for testing newly developed systems such as
electronic prescriptions.
97
The introduction of electronic communication methods is one
key aspect in the envisioned e-health design. Section 67 (1) SGB V
states the goal to significantly improve both the quality and the
economics of healthcare by employing electronic communication.
98
Electronic communication is viewed to be indispensable especially for
integrated care concepts and disease management programs.
99
Therefore, paper-based communication among the health service
providers - including clinical findings, diagnoses, therapy
recommendations and therapy reports - is intended to be eliminated and
92 Gerrit Hornung, DIE DIGITALE IDENTITAT - RECHTSPROBLEME VON
CHTPKARTENAUSWEISEN: DIGITALER PERSONALAUSWEIS, ELEKTRONISCHE
GESUNDHEITSKARTE, JOBCARD-VERFAHREN 43 (2005); Korbinian H6fler, SGB V, §
63, No. 2-3 in KASSELER KOMMENTAR SOZIALVERSICHERUNGSRECHT, supra note 32.
93 H6fler, supra note 92.94 Id. at No. 5.
95 id.
96 Id. at No. 3 and 6.
97 Id. at No. 6.
98 d.at § 67 at No. 2.
99 Id.
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replaced with electronic communication as soon and as
comprehensively as possible.100 The provision is to be seen in
connection with section 291a SGB V, regulating the further
development of the already introduced insurance card into an electronic
health card. The electronic health card is envisioned to be an essential
component in the future electronic data transfer among service
providers. 1° 1 Section 67 (2) contains the mandate for health insurance
providers to financially support the shift from paper-based to electronic
communication. 10 2 The new electronic health card will be mandatory
for those covered by statutory health insurance.' 
03
Electronic insurance cards have been in use since 1995. They
enable statutory health insurances to electronically transfer the basic
patient data into physicians' data processing systems which previously
had been entered by hand.'0 4 The current electronic insurance card is a
simple storage card without a processing device. There are no safety
features such as personal identification numbers and the cards are not
write-protected. °5 These existing insurance cards are to be developed
into electronic health cards, containing data regarding the insured
person, emergency treatment, patient medical history, medication
documentation, and medical services rendered as well as their costs.' 
06
Further, the cards must be suited to be used for the transmission of
prescriptions and proof of entitlement to receive health services within
the EU. 10 7 Section 291a SGB V regulates the content of the electronic
health card, data access, and the financing of an accompanying
organizational structure that creates a new agency, the Geselschaftftir
Telematik.10 8 On the basis of calculations in 2004, the electronic
prescription was to be the primary use area of the electronic health card
as it was deemed the most likely to recover the costs for introduction of
the card. Once 500 to 600 million prescriptions were to be transmitted
'
0
' Id. at No. 3.
101 Id. at No. 4; Hornung, supra note 92, at 43.
102 H6fler, supra note 92, at No. 5.
103 Hornung, supra note 92, at 60.
104 ld at 42.
105 Id.
106 HtSfler, supra note 92, at No. 4; Homung, supra note 92, at 42. See also Wolfgang
Kilian, Rechtliche Aspekte bei Verwendung von Patientenchipkarten, 45 NEUE
JURISTISCHE WOCHENSCHRIFT [NJW] 2313 (1992).
107 H6fler, surpa note 92, at No. 4; Homung, supra note 92, at 44.
1o8 Karl Peters, SGB V, § 291a, No. 2, in KASSELER KOMMENTAR
SOZIALVERSICHERUNGSRECHT, supra note 43. See also Hornung, supra note 92, at 45
(for more on the gematik Gesellschaft fiir Telematikanwendungen der
Gesundheitskarte GmbH); Id. at 372-374 (for an analysis of organization aspects).
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electronically, the estimated investment of 1.3 billion Euros was to be
recovered within about three years. 109 Possibly the e-prescription is the
only application with short-term economic benefits. 10
Asserted benefits for the patient include a better ability to
determine the use of data. Saving data on or with a chip card can give
the insured individual the ability to independently decide on the use of
his or her data, depending, of course, on the technical design of the data
access. Patients could thus receive more information on treatment and
costs. For the service providers, the asserted key benefit is the
improvement of the level of care by faster and more reliable data
access. Further, there are new possibilities regarding e-consults and
cooperation among hospitals. Moreover, reducing administrative tasks
leads to a reduction in costs."' The system of the electronic health card
also encompasses the introduction of the health professional card which
in most cases will be necessary to access the data. The health
professional card will enable the creation of qualified electronic
signatures. Although this is not necessary for the electronic health card,
they, too, can be used for qualified electronic signatures. 112 The
contents of the electronic health card are divided into a mandatory and
a voluntary part. The mandatory part includes three parts: the storage of
basic patient data, the transmission of the e-prescription and the storage
of the EU proof of entitlement." 3 The voluntary part, which under
section 291a (3)(3) SGB V will only be stored on the card with the
insured individual's prior consent, are medical emergency data, the
electronic discharge letter, the electronic medical record, the data
regarding pharmaceutical product safety, data provided by the patient
regarding previous medical services and their preliminary costs (patient
receipt).
Although there has been intense work toward the introduction
of the electronic health card, it is still in the trial phase." 5 One reason
the introduction of a widely used electronic health card requires
109 Doris Pfeiffer, Stand und Perspektiven der Gesundheitstelematik aus Sicht der
gesetzlichen Krankenversicherung 35-36 in eEurope 2005, supra note 17. Hornung,
supra note 92, at 43 cites a recovery of costs of 1.2 to 1.5 billion Euros within only 1
to 2 years. See also Hornung, supra, note 92, at 374-375(for an overview of the costs
involved).
110 Homung, supra note 92, at 209.
11Id. at 44.112 Id. at46.
1 3 Id. at 61.
114 Id. at 207.
1 " Id. at 44-45.
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significant efforts is the vast amount of data. Around 70 million
individuals are members of the public health insurances (amounting to
roughly 90% of the German population) and the public heath insurance
itself is divided into numerous subsections." 6 The provision of section
291 a, however, has been subject to criticism, mainly because of what is
asserted to be a general problem of modem legislation: section
291aSGB V appears to be obsessed with detail regulations." 7 The data
protection-inspired regulations regarding the information of the insured
individuals and their consent are well-intended; however, it has been
pointed out that the execution of such detailed rules in mass-
transactions such as the introduction of an electronic health card may
be neither practical nor verifiable. 1' 8 Further, since a new agency is
established, it has been argued that the stated objective to decrease
bureaucracy has not been achieved.'1 19
The new provisions concerning the electronic insurance card
were challenged in a constitutional complaint (Verfassungsbeschwerde)
before the Federal Constitutional Court. 120 The petitioner alleged the
violation of his constitutional right to informational self-determination
under Article 2(1) in connection with Article 1(1) of the Basic Law. In
addition, he claimed violations of the general equality clause, Article
3(1). Although the Court did not address the merits for lack of standing,
it did state that the petitioner had raised significant constitutional
questions. The petitioner, however, did not have standing because he
had not exhausted all remedies before filing his complaint. 12 1 As an
extraordinary remedy, constitutional complaints can only be filed after
a final judgment of a court has been rendered. 22 It does not appear
inconceivable, however, that the issue may return to the courts in the
future. The significant data protection issues as well as the electronic
signature issues raised in connection with the electronic health card will
be outlined and analyzed in further detail below.
123
116 Peters, supra note 43, at No. 4; Kilian, supra note 106, at 2314.
117 Peters, supra note 43, at No. 4.
118 id.
119 Id.
120 Bundesverfassungsgericht [BVerfG] [Federal Constitutional Court], Feb 13, 2006,
docket no. 1 BvR 1184/04.
121 Id.
122 Alfred Rinken, The Federal Constitutional Court and the German Political
System, in CONSTITUTOINAL COURTS IN COMPARISON: THE U.S. SUPREME COURT
AND THE GERMAN FEDERAL CONSTITUTIONAL COURT 55, 67 (Ralf Rogowski and
Thomas Gawron eds., 2002).
123 Infra Parts II and III.
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Ideally, electronic medical records enable "any doctor anywhere
to access the full profile of any patient anywhere."' 124 The EU
Commissioner for Information Society & Media pointed out that the
Czech Republic already has implemented a personal electronic medical
125record. In Germany, section 68 SGB V contains a provision allowing
for the financial support of electronic medical records by the health
insurance companies records intended to improve the quality and
economics of medical care especially in the framework of the public
health insurance. 126 According to section 68 SGB V, electronic health
records contain patient related health data of the insured individuals, for
example relevant medical information regarding previous diagnoses. 127
The electronic medical record is specifically designed to support the
goals of integrated care and the improvement of communication
between individual physicians involved in patient care. 128 The use of
the electronic medical record is said to have advantages for both the
patient and the healthcare provider. It eliminates administrative tasks
on the part of the physician and leads to a higher transparency as both
the patient and the physicians have access to the same information. 129
3. Challenges and Restrictions
Managed care and medical call centers providing advice to
insured persons by the insurance companies face various legal
restrictions. As a general matter, section 3 of the Unfair Competition
Act (Gesetz gegen den unlauteren Wettbewerb, UWG) has to be
observed. Information regarding medical products and service
providers has to be objective and factually substantiated and cannot
contain one-sided advertisings.130 Aside from such general laws,
medical health professionals are subject to further professional
regulations.
Recommending physicians is subject to the regulations of the
prohibition of advertising contained in section 27 of the Model Code of
Professional Conduct for Physicians (Musterberufsordnung fJr %rzte)
124 Martin, supra note 1.
125 Reding Interview, supra note 11.
126 H6fler, supra note 92, at § 68, Rn. 2
127 Id at No. 3
128 Id at No. 4
129 Pfeiffer, supra note 109, at 38.
130 Bach & Hiitt, supra note 59, at No. 85.
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which, though sections 3 and 4 No. 11 of the Unfair Competition Act
(formerly section 1 UWG) also applies to the insurances. As a general
matter, recommending individual physicians is impermissible. 131
However, listing medical specialists without a qualitative ranking is
permissible as patients have an interest in learning of methods designed
to treat a specific illness and of the health care providers who offer
them. 32 Antitrust regulations create restrictions on recommendations
made by the health insurance if they are (indirectly) addressed at the
healthcare provider. The Act against Restraints on Competition (Gesetz
gegen Wettbewerbsbeschrdnkungen, G WB) in section 21 prohibits
boycotts. If, for example, the insurance recommends specific dental
labs and the insured passes on this recommendation to the dentist, who
is a businessperson in the sense of the GWB, this might be regarded as
an indirect request of the insurance, addressed at the dentist, to prefer
certain dental labs. A boycott in the sense of section 21 GWB
encompasses any attempt to influence another businessman to refrain
from entering into or keeping up certain supply relationships. If dentists
commission a specific dental lab in order to avoid billing problems for
patients, this already constitutes such interference.133 If this is not the
case, however, tips on cheap services of certain providers are
permissible. 34 General information regarding appropriate prices of
dental lab services is permissible. While providers of statutory health
insurance are expressly permitted under section 88 (2)(3) SGB V to
inform their members as well as dentists of economical service
opportunities, a complementary provision does not exist for private
insurances.' 35
Medical advice offered by medical call centers via the telephone
is subject to professional regulations for physicians. Important
professional conduct provisions concern the diligent exercise of
professional duties (section 2 (2) of the Model Code of Professional
Conduct) and the tenet of personal rendering of services (section 7 (3)
of the Model Code of Professional Conduct, stating that the physician
may not perform individual treatment and consulting exclusively via
131 See Federal Court of Justice [Bundesgerichtshof][BGH] 16 MEDIZINRECHT [MEDR]
131 (1998); Regional Court of Appeals of Munich [OLG Mtinchen] 17 Medizinrecht
[MedR] 76 (1999).
132 See District Court Kiel [LG Kiel] 17 Medizinrecht [MedR] 279 (1999).
133 Federal Court of Justice [Bundesgerichtshof][BGH]49 WIRTSCHAFT UND
WETTBEWERB [WuW] 725, 727 (1999).
134 Federal Court of Justice [Bundesgerichtshof][BGH] decision of March 14, 2000,
docket no. KZR 15/98.
135 Bach & Hfitt, supra note 59, at No. 87.
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telecommunication media.) This means that individual medical advice
may only be disseminated after personal contact. Diagnoses may not be
made over the phone and no concrete therapy suggestions may be
made. Health advice over the phone may only be concerned with
general health questions which may also be found in literature,
including generally which groups of diseases might be considered in a
given case and what the general criteria of these diseases might be.136
Considering possible liability risks, it is considered advisable that the
insurance refrain from further consulting as well. 1
37
Restrictions also apply in the area of pharmaceutical products.
In connection with medications, the provisions of the Law on the
Advertising of Medicinal Products (Heilmittelwerbegesetz, HWG) have
to be observed. Advertising prescription drugs to consumers is
prohibited. Further, no advertising is allowed regarding medications for
specific illnesses and ailments. 138 Outside of online order pharmacies,
as was the subject of the DocMorris decision of the ECJ, there are
specific questions regarding online advertising for drugs.14 Posting the
package inserts for prescription drugs online has been the subject of
several lawsuits. While posting the package inserts was not deemed
unlawful online advertising by the Munich district court and regional
court of appeals, the district court of Hamburg took the opposite
stance. 141 Beyond questions of advertising, pharmaceuticals are highly
regulated in Germany. As in most European states, the prices of drugs
are not set solely by the market but instead are subject to state
regulation. The authorization for regulating the prices of drugs
originates in section 78 of the Law on Medicinal Products
(Arzneimittelgesetz, AMG).14 2 Based on the authorization, the
Regulation on Prices of Medicines (Arzneimittelpreisverordnung, APO)
regulates the prices at which prescription drugs are sold to consumers.
136 Regional District Court Heidelberg [LG Heidelberg] 17 MEDIZINRECHT [MEDR]
420 (1999).
137 Bach & Hiltt, supra note 59, at no. 88.
138 Id. at no. 85.
'
39 Infra Part IV.
140 Ralph Alexander Lorz, Internetwerbung far verschreibungspflichtige Arzneimittel
aus gemeinschafisrechtlicher Perspektive, 54 GEWERBLICHER RECHTSSCHUTZ UIND
URHEBERRECHT INTERNATIONALER TEIL [GRUR INT] 894 (2005).
141 LG MiInchen, decision of November 6, 2003, docket no. 17 HKO 7494/03; OLG
Mfinchen, decision of May 6, 2004, docket no. 6 U 5565/03.
142 Elmar Mand, Internationaler Versandhandel mit Arzneimitteln - Das Ende der
einheitlichen Apothekenverkaufspreise gemdfj AMPreisV?, 54 GEWERBLICHER
RECHTSSCHUTZ UND URHEBERRECHT INTERNATIONALER TEIL [GRUR INT] 637, 638
(2005).
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While manufacturers may freely set prices for their drugs, the APO
imposes fixed prices and maximum prices for prescription drugs to be
sold in pharmacies, thus eliminating competition of pharmacies in the
area of prescription drugs.' 43 The goal of the regulation is to keep the
prices of prescription drugs low in the interest of a well-functioning and
affordable health care system. 144 Further areas of conflict between e-
health initiatives and the highly regulated pharmaceuticals market will
be illustrated in the context of online pharmacies. 1
45
II. E-HEALTH AND DATA PROTECTION
This section will illustrate a few key issues of crucial
importance for the future success of e-health initiatives in Germany and
Europe. Data protection and data security have been identified as
critical factors in the success of e-health as they directly relate to the
trust of the patient and the reliability of electronic processes. 146 The
European Commission identifies data protection and data security as
major challenges for the wider implementation of e-health concepts. 147
A variety of rules govern data protection on the European and German
national level. A rough overview of these regimes will be given in this
section, starting with the general laws on data protection and then
turning to the area-specific data protection provisions in the area of
healthcare including transnational health data processing. Finally, the
key concerns regarding data access and protection in connection with
the electronic health card will be illustrated.
143 Id.
144id
141 Infra Part IV.
146 Heinz Thielmann, Datenschutz und Datensicherheit - Kritische Erfolgsfaktoren far
eHealth 195, 195 in EHEALTH, supra note 82.
147 e-Health Action Plan, supra note 8, at 14.
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A. General Data Protection Regime
In Germany, the first data protection efforts started in the 1970s
on the state (Lander) level. 148 The very first general data protection law
worldwide, in fact, was implemented in the state of Hesse in 1970.149
In 1977, the first national data protection act was implemented which in
its entirety entered into force in 1979.150 A milestone in the area of
German data protection was a 1983 decision of the Federal
Constitutional Court. In its census decision (Volkszdhlungsurteil), the
Court held that there is an unwritten fundamental right to informational
self-determination based on Articles 1 and 2 of the German
Constitution, the Basic Law (Grundgesetz).151 This fundamental right
guarantees that the individual maintains control over the disclosure and
use of personal data, including the right to decide when and within
which limits personal information is revealed. In addition, the
individual must know who knows what at a given point in time.'
52
Although the Court acknowledged that there are limits to this right, it
developed strict requirements for such limits. They are only permissible
on the basis of a law codifying an overwhelming common interest. The
conditions of the limits on freedom of informational self-determination
have to be unambiguous. Further, the requirement of proportionality
must be observed. The collection and processing of personal data is
subject to a further strict requirement, the specified purpose. Personal
data may only be collected for a specified purpose and can neither take
place for any other than the originally stated purpose nor in advance for
an unspecified purpose. Finally, the amount of data has to be kept to the
absolutely necessary minimum. 153
148 Wolfgang Durner, Zur Einffhrung: Datenschutzrecht, 46 JURISTISCHE SCHULUNG
[JuS] 213 (2006); Spiros Simitis, Einleitung - Geschichte, Ziele, Prinzipien, No. 1 in:
BUNDESDATENSCHUTZGESETZ (Spiros Simitis, ed., 6th Edition, 2006).
149 Peter Gola & Rudolf Schomerus, BDSG BUNDESDATENSCHUTZGESETZ
KOMMENTAR, Einleitung, No. 1 (7th Edition 2002).
150 Dumer, supra note 148, at 213; GOLA AND SCHOMERUS, supra note 149, at
Einleitung, No. 1.
151 Bundesverfassungsgericht [BVerfG] [Federal Constitutional Court], Dec 15, 1983,
65 ENTSCHEIDUNGEN DES BUNDESVERFASSUNGSGERICHTS [BVERFGE] 1 (F.R.G.)
[hereinafter: Census decision].
152 Dumer, supra note 148, at 213.
153 Id at 214.
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The fundamental right to informational self-determination is
primarily protected by the Federal Data Protection Act154
(Bundesdatenschutzgesetz, BDSG) and the data protection acts of the
states, all of which underwent major changes following the European
Data Protection Directive.155 In addition to this general data protection
legislation, special legislation exists in a wide variety of area-specific
laws. Data protection hence is identified as a typical cross-section of
legal regulations that is not subject to a uniform legislative
competence. 156 The reason for the multitude of legislative competences
is the absence of a competence title regarding data protection in the
Basic Law. 157 The general data protection laws, such as the Federal
Data Protection Act in section 1(4), contain subsidiarity clauses so that
in any given instance, the area-specific data protection regulations take
precedence.1
58
Especially interesting in the data protection context are
questions of utilizing third parties for data processing services.
Oftentimes, automated data processing is not performed by the
responsible entity, the principal, itself. The BDSG in section 11
provides the privileged instrument of commissioned data processing
(Auftragsdatenverarbeitung). The provision is intended to ensure that
the data protection and data security standards imposed by the BDSG
do not limit the possibility of outside data processing. The
commissioned data processing provider legally is seen as forming a
single entity with the principal. 159 In other words, those who engage in
commissioned data processing are not considered "third parties."' 160 If
personal data is gathered or employed, i.e., processed or used under
section 3(5) BDSG) by way of commissioned data processing, the
special provisions of section 11 (1)(1) BDSG apply. The provider of
154 See
http://www.bfdi.bund.de/cln_029/nn 946430/EN/DataProtectionActs/Artikel/Bundes
datenschutzgesetz-
FederalDataProtectionActtemplateld=rawproperty=pubicationFie.pdf/Bundesdaten
schutzgesetz-FederalDataProtectionAct.pdf (for an English translation) (last visited
Oct. 30, 2008).
55 Directive 95/46/EC of the European Parliament and of the Council of 24 October
1995 on the protection of individuals with regard to the processing of personal data
and on the free movement of such data. See Simitis, supra note 148, at No. 89 - 102
(providing a detailed account of the legislative process incorporating the changes).
156 Dumer, supra note 148, at 214; Simitis, supra note 148, at No. 48.
157 Dumer, supra note 148, at 214.
158 Id.
159 Stefan Walz, § 11 No. 1 in BUNDESDATENSCHUTZGESETZ, supra note 148.
160 Gola & Schomerus, supra note 149, at § 11 No. 3.
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commissioned data processing only has to ensure that the technical and
organizational measures are in place to provide for data availability,
integrity and privacy. Beyond that, all responsibility regarding the
compliance with data protection provisions remains with the principal
entity that remains the "responsible entity" in the sense of section 3(7)
BDSG. Thus, only the principal entity is liable in relation to third
parties. 16 1 Notably, the individual whose data is transferred by way of
commissioned data processing is not required to consent to the
transfer. 162
The problem, however, is to identify the privileged instances of
commissioned data processing. The BDSG does not provide clear
identification guidelines.1 63 Commissioned data processing is to be
distinguished from "functional assignments" (Funktionsiibertragung).
A functional assignment involves not only the transfer of parts of
automated data processing but rather the entire task for which the data
processing takes place.' 64 Several criteria have been suggested to
identify commissioned data processing. Most importantly, the service
provider does not have any competences regarding the data and
depends entirely on the demands of the principal, especially regarding
the type and scope of data it gathers and/or uses and only exercises a
supporting or auxiliary role. 165 Moreover, the focus of the service
provided in commissioned data processin 66generally is the purely
technical performance of data processing. On the other hand, a
functional assignment can be assumed if the underlying business
processes are entirely or partially handed over or if the external data
processor fulfills his own business objectives, especially if he performs
material contractual services with the data provided. Then, the service
provider is no longer merely a contractor but (insofar) becomes the
responsible entity. 167 Criteria suggested to identify a functional
assignment are, first, the service provider has independent decision
competences regarding the manner of data processing and the selection
of the data. The tasks are independently carried out and the principal
161 Philipp Kramer & Michael Herrmann, Auftragsdatenverarbeitung, 19 COMPUTER
UND RECHT [CR] 938 (2003).
162 Mark Hoenike & Lutz Htilsdunk, Outsourcing im Versicherungs- und
Gesundheitswesen ohne Einwilligung? 7 MULTIMEDIA UND RECHT [MMR] 788
(2004).
163 Kramer & Herrmann, surpa note 161, at 938.
164id.
165 Id.; Walz, supra note 159, at No. 1.
166 Kramer & Herrmann, supra note 161, at 938.
167 Simitis, supra note 148, at § 11 No. 17.
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generally has little or no influence over the data processing itself.
Sometimes, a further indication is that a service is provided that goes
beyond the mere technical assignment of data processing and, even
further, the service provider may have the right to use the data for own
purposes and has an own interest in the use of the data.' 68 If the data
processing occurs in part for own purposes and in part because of a
commissioning, the commissioning provisions only apply to the
commissioned part. The quantitative volume of each part is irrelevant.
Such a split legal situation particularly occurs with data processing
centers that in addition to the data supplied for commission purposes
also process for themselves data of their employees and clients.' 
69
B. Healthcare-Specific Data Protection
"Whatever I see or hear in the lives of my patients, whether in
connection with my professional practice or not, which ought not to be
spoken of outside, I will keep secret, as considering all such things to
be private."' 170 This passage of the Hippocratic Oath has been referred
to as one of the oldest data protection laws.' 71 The protection of
medical data is subject of the physicians' professional code of conduct
as well criminal prohibitions' 72 and data protection regulations. Data
protection in the health care area is especially sensitive due to the
special relationship based on mutual trust between the patient and the
physician. The protection of medical data thus is indispensable. The
scope of the confidentiality requirement is wide, concerning not only
the diagnoses but even the fact of the doctors' visit as such. Everyone
who does not take part in the treatment procedure itself is excluded
from access to the protected information, including other physicians not
involved in the treatment. Passing on medical information is only
permissible with express consent of the patient.' 73 Members of
statutory health insurance, however, are subject to the assumption that
168 Kramer & Herrmann, supra note 161, at 939.
169 Simitis, supra note 148, at § I iNo. 19.
170 Hippocratic Oath, Translation, available at National Institutes of Health
http://www.nlm.nih.gov/hmd/greek/greek-oath.html (last visited Nov. 12, 2008).
171 Helge Sodan, Verfassungs- und europarechtliche Grundlagen des Medizinrechts,
18, in HANDBUCH DES FACHANWALTS MEDIZINRECHT, supra note 43.
172 See Hoenike & Hiilsdunk, supra note 162(for an in-depth discussion of the
criminal law implications of outsourcing in the area of insurance and healthcare).
173 Sodan, supra note 160, at 18; Frank Wenzel, Das Recht der medizinischen
Behandlung, 221, 307-308, in HANDBUCH DES FACHANWALTS MEDIZINRECHT, supra
note 43.
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they at least implicitly agree with the transmission of all relevant data,
including the diagnosis, to assess the obligation of the insurance to
cover the costs incurred (section 60 SGB I), but disclosure of these
facts has to be contained to the amount of information necessary.
74
When considering the connection between the confidentiality
requirement, the documentation requirement, and data protection
provisions, there has to be a distinction among the different uses.
Collecting data is part of the treatment contract since treatment without
the health information is impossible. At the same time, it allows only
for the gathering of data immediately necessary for the treatment
itself.175
As already mentioned, the area-specific data protection
legislation takes precedence over the general data protection legislation.
In the area of healthcare, such area-specific data protection legislation
is contained primarily in the 1 0 th book of the Social Insurance Code,
SGB X. Medical data protection not only protects the patient-physician
relationship but also the patients' fundamental right to informational
self-determination.' 76 The area-specific legislation of the SGB X, too,
was subject to changes based on the EU data protection directive.177 It
has been argued, however, that prior to the implementation of the EU
data protection directive the provisions of the SGB X largely
conformed to the directive. On the other hand, generally applicable
changes, such as definitions as well as information rights, data transfer
abroad and to trans- and international entities, had to be incorporated in
to the social insurance code, especially into the SGB X, because this
data protection regime is area-specific and insofar precedes the
BDSG.
178
One of the key questions is when and how personal data
becomes social data, of which health data is a subset. Section 67 (1)(1)
SGB X states that personal data becomes social data when it is
gathered, processed or used by an entity enumerated in section 35 SGB
I (usually a social insurance provider) in the framework of activities
under the social insurance code. 179 Of course, not every activity of a
social insurance provider is an activity under the social insurance code.
174 Sodan, supra note 171, at 18. See also Hoenike & Hillsdunk, supra note 162.
175 Hornung, supra note 92, at 60.
176 Sodan, supra note 171, at 18.
177 See, e.g., Robert Steinbach, Die Umsetzung der EG-Richtlinie Datenschutz im
Sozialgesetzbuch, 11 NEUE ZEITSCHRIFT FOR SOZIALRECHT [NZS] 15
(2002)(providing an overview of the changes).
'
78 Id. at 16.
179 Id.; Sodan, supra note 171, at 18.
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For example, there might be personal data related to employees of the
social insurance provider which may be gathered, processed or used
there, but do not constitute social data, as employment with a social
insurance provider is not subject to the social insurance code.1 80
In the area of health data processing, too, questions of third
party involvement are of special interest. As already stated, before
employing the general provisions of the BDSG, possible area-specific
rules have to be considered. 181 Thus, before turning to section 11
BDSG in the area of health data processing, the provisions of the SGB
have to be examined. Social insurance providers fall under the regime
of section 80 SGB X as far as commissioned data processing is
concerned. Commissioned data processing in the sense of section 80
SGB X is given if the entity at which the data is stored uses a service
contractor to perform the processing of social data but who, regarding
the manner and extent of data processing, entirely depends on the
requests of the storing entity.182 It is, in other words, the same
mechanism as in section 11 BDSG. This, however, only applies in the
area of social insurance. A special feature of the SGB, however, is that
social data includes not only personal data but also trade and business
secrets. If, as in the example above, data processed outside is for
purposes of employment with the insurance provider and therefore does
not constitute social data, section 11 BDSG applies.1
83
Transnational health data processing poses a number of
questions. Section 77 SGB X regulates the transmission of social data
abroad or to a supranational or international entity. The provision was
changed to take into account the harmonization of the data protection
level among EU Member States under the EU data protection directive.
Data transmissions within the EU and in countries with an adequate
level of data protection are to be treated differently than data
transmissions to third countries without an adequate level of data
protection. 184 The provision primarily concerns transmissions to service
providers (for example insurance providers or hospitals, etc) who
exercise the same functions as Genrman social insurance providers under
section 35 SGB I. While a complete identity is not necessary, a
180 Steinbach, supra note 177, at 16.
18' Walz, supra note 159, at No. 7.
182 Dirk Bieresborn, § 80 No. 3 in SGB X SOZIALVERWALTUNGSVERFAHREN UND
SOZIALDATENSCHUTZ KOMMENTAR (Matthias von Wulffen, ed., 5th Ed., 2005).
183 Walz, supra note 159, at No. 9.
184 Bieresborn, supra note 182, at § 77 No. 2; Steinbach, supra note 177, at 21.
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functional equivalence must exist. 185 Section 77 (2) makes the
provision applicable to non-EU Member States if they have an
adequate level of data protection. The entities determining whether an
adequate level of data protection exists are the Federal Insurance
Agency (Bundesversicherungsamt) along with the German Foreign
Office (Auswdirtiges Amt) and the Federal Ministry of the Interior
(Bundesministerium des Innern) in close cooperation with the European
Commission. 186 Further, section 77(3) declares the transfer of data
abroad to be permissible if the data subject has declared his consent
(No. 1), or the transmission is based on a treaty in the area of social
security (No. 2), or the data transmission is necessary for a criminal
trial or other court procedure (No. 3). In the cases of section 77 (3) No.
3 SGB X, however, an appropriate level of data protection has to be
present. An additional limit on the transmission under section 77(3) is
that the individual has no legitimate interest in preventing the
transmission.' 87 Legitimate interests in this context include the
possibility that the transmitted data can lead to racial, religious or
political discrimination of the individual or if they can be used to draw
conclusions regarding possible violations of the laws of other states by
the individual. 188
A question that might arise in the area of transnational health
data processing is whether a managed care service provider operating
in another EU Member State can access data stored on the server of a
statutory health insurance provider in Germany to evaluate the data for
health coaching programs in the area of chronic illnesses. Under the
standards outlined above, data transmission and access within the EU is
generally permissible.
C. Data Access, Data Protection, and the Electronic Health Card
Specific data protection related issues have been raised in
connection with the introduction of the electronic health card (patient
chip card). The key question concerns the control over the card itself
and the stored data. With regard to the electronic health card, the
provisions regarding storage, transmission and use of personal data are
especially important. 189 The most recent health modernization
185 Bieresborn, supra note 182, at § 77 No. 5; Steinbach, supra note 177, at 21-22.
186 Bieresbom, supra note 182, at § 77 No. 8; Steinbach, supra note 177, at 23.
187 Bieresborn, supra note 182, at § 77 No. 9; Steinbach, supra note 177, at 23.
188 Bieresbom, supra note 182, at § 77 No. 9.
189 Kilian, supra note 106, at 2316.
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legislation concerns the use of data that in the past have been gathered,
processed and used. The provisions governing this data are also
applicable to the electronic health card. 190 A central problem, however,
is the large number of interfaces that would have to be programmed in
a manner to ensure that indeed only the authorized individuals have
access to the data. 19' In connection with the electronic health card, large
quantities of personal data are processed which contain information
regarding the individual's health. As already mentioned, health data is
to be interpreted widely, an approach that is also shared by the
European Court of Justice.' 92 While the majority of voluntary
applications of the electronic health card would fall under data section
3(9) BDSG 193 (i.e., data regarding the racial or ethnic origin, political
opinions, religious or philosophical beliefs, union membership, health,
or sex life) only the e-prescription is a mandatory application falling in
this category as it contains information pertaining to health. No such
data can be taken from the EU proof of entitlement or the basic data.
1 94
If, however, the card contains a photo of the individual this is to be
interpreted as data regarding the racial or ethnic origin. 195
In principle, the electronic health card is regulated by a
comprehensive legal framework. However, the law does not provide
any detailed technical requirements for implementation. 196 Section
291 a SGB V states explicitly that data has to be stored on the card in
electronic form, which means that it has to be a chip card. Moreover, it
has to enable authorization by the insured individual. There is no
provision governing the place of storage, though. Possibilities include
storage of the data on the card itself or on decentralized or centralized
servers. 
197
The Federal Court of Justice has held that the patient generally
has the right to determine the fate of the patient data rather than the
physician. 198 However, it has been pointed out that complete control of
the patient may not sufficiently serve the interests of all parties
190 Hornung, supra note 92, at 58.
191 Sodan, supra note 171, at 19; Hornung, supra note 92, at 363.
192 Hornung, supra note 92, at 278.
193 Id.
"' Id. at 279.
195 Id.
'
9 6 Id. at 58.
191 Id. at 211-212. See also Id. at 213-218(discussing the various storage possibilities).
198 See, e.g., Federal Court of Justice [Bundesgerichtshof][BGH] 45 NEUE
JURISTISCHE WOCHENSCHRIFT [NJW] 763 (1992). See also Kilian, supra note 106, at
2316.
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involved since the physician has various obligations in connection with
the data as well. For example, the physician is obliged to maintain
proper documentation. Exclusive control of the data by the patient
would prevent the physician from fulfilling her duty. 199 The issue of
data access on the electronic health card has to be seen in connection
with the central demands of data protection which include the
requirement to only collect data for a specified purpose and to avoid the
uncontrolled confluence of data collected for different purposes. To
ensure these demands of data protection, it has been suggested that all
individual applications of the electronic health card have to be stored
and processed separately. 200 Patients, it is rightly pointed out, are in a
conflicting position. On the one hand, only the disclosure of health data
enables the physician to effectively offer treatment. On the other hand,
the disclosed data is processed and used in ways that are outside the
control of the patient. 20 ' Further, the autonomy of the patient
encompasses the right to freely choose a physician, the right to refuse
treatment, and the right to freely decide which information to disclose
to the health service provider. The patient must have the opportunity to
get an independent second opinion. This, however, is made virtually
impossible by disclosing the entire medical history to each physician.20 2
On the other hand, the physician may not receive all information
necessary regarding medical history because the patient may not
consider it relevant or withholds the information for whatever
reason.20 3 Some applications only make sense if they are complete and
current. This requires that the card be used for documentation of every
treatment and medication.20 4
III. ELECTRONIC SIGNATURE
Generally, the use of electronic signatures is intended to
eliminate the risks of using digital methods of communication that can
arise on the side of the sender as well as on the side of the recipient.
20 5
199 Hornung, supra note 92, at 215.
200 Id. at 218.
201 Id.
202 Id. at 209-210.
203 Idat 210.
204 id.
205 Frank Bitzer & Klaus Brisch, DIGITALE SIGNATUR: GRUNDLAGEN,
FUNKTION UND EINSATZ (1999), 127.
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These risks include the uncertainty of origin of a message and the
possibility of tampering with or intercepting messages during the
transmission process. The use of electronic signatures has the goal to
provide solutions for technical and legal security in transmitting
messages online. The electronic signature is to be used in several ways
in the e-health context. According to the German federal government's
"e-Card Strategy" of 2005, the electronic health card - which should
have been introduced at the beginning of 2006 but currently is in trial
phases in eight regions throughout Germany - is intended to be
equipped with the capacity to generate qualified electronic
signatures.206 Consequently, section 291 (2a) SGB V states that the
electronic health card must enable the patient to authenticate, encode,
and generate electronic signatures. 20 7 Further, electronic health records
are outfitted with electronic signatures to ensure procedural evidence
quality.20
8
A. The German Signature Act
The use of electronic signatures is governed by the German
Signature Act (Signaturgesetz, SigG) of 1997, the first national law
worldwide governing the basic technical and organizational
requirements concerning the safety infrastructure of electronic
signatures. 20 9 The original 1997 version was reformed in 2001 on the
basis of the EU Directive on Electronic Signatures (Directive
1999/93/EC of the European Parliament and the Council of December
13, 1999). The key to understanding German electronic signature law
presents itself as follows. The Civil Code (Biirgerliches Gesetzbuch,
BGB) of January 1, 1900, defines the written form as necessarily
containing a manual signature. 210 As this fundamental one hundred year
206 Hornung, supra note 92, at 313; Alexander RoBnagel, Die Ausgabe sicherer
Signaturerstellungseinheiten, 9 MULTIMEDIA UND RECHT [MMR] 441, 442 (2006).
2 Hornung, supra note 92, at 313.
208 RALF BRANDNER, DIGITALE SIGNATUR VON DOKUMENTEN IM KRANKENHAUS 9
(2002).209Alexander RoBnagel, Signaturgesetz, No. 1 in RECHT DER MULTIMEDA-DIENSTE
KOMMENTAR (Alexander RoBnagel, ed., 6th Update, 2005).
210 Section 126 Written form
(1) If written form is prescribed by statute, the document must be signed by the issuer
with his name in his own hand, or by his notarially certified initials.
(2) In the case of a contract, the signature of the parties must be made on the same
document. If more than one counterpart of the contract is drawn up, it suffices if each
party signs the document intended for the other party.
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old concept remains unchanged, section 126a211 was enacted to codify
the variation of section 126 (3) which allows the electronic form. Under
section 126a, only qualified electronic signatures under the Signature
Act fulfill the requirements of the written form pursuant to section 126
of the Civil Code and can thus replace the manual signature.
The electronic signature under the Signature Act provides
security in two areas: first, the identity of the communication partner
and, second, the integrity of the data communicated. To achieve this
goal, messages are outfitted with an electronic signature using a
mathematical transformation. From the information to be signed,
consisting of a number of bits, a value is generated whose length
according to the permitted procedure under the Signature Act is 160 bit.
This value is akin to a finger print, the so-called hash value. 212 The
verification of the value makes it possible for the recipient to ascertain
that the signed message indeed originated from the sender claiming to
have sent the message. This is commonly referred to as the authenticity
of data origin. Moreover, upon verification of the signature, the
recipient can tell whether the data has been manipulated or whether the
data is still intact. Only if there are no changes to the original message a
positive result indicates that the transmitted data is intact.213
The law generally distinguishes between simple (section 2 No.
1 Signature Act), advanced (section 2 No. 2 Signature Act), qualified
(section 2 No. 3 Signature Act) and accredited qualified (section 2 No.
3, section 15 (1)(4) Signature Act) electronic signatures.
The first two do not meet the legal requirements of section 126a of the
(3) Written form may be replaced by electronic form, unless the statute leads to a
different conclusion.
(4) Notarial recording replaces the written form.
Translation: Federal Ministry of Justice/Juris GmbH:
http://bundesrecht.juris.de/englisch-bgb/index.html (last visited: Oct. 30, 2008).
211 Section 126a Electronic form
(1) If electronic form is to replace the written form prescribed by law, the issuer of the
declaration must add his name to it and provide the electronic document with a
qualified electronic signature in accordance with the Electronic Signature Act
[Signaturgesetz ].
(2) In the case of a contract, the parties must each provide a counterpart with an
electronic signature as described in subsection (1).
Translation: Federal Ministry of Justice/Juris GmbH, supra note 210.
212 Britta E. Brisch & Klaus M. Brisch, Elektronische Signatur und Signaturgesetz,
No. 1-3 in HANDBUCH MULTIMEDIARECHT (Thomas Hoeren and Ulrich Sieber, eds.,
17th Update, 2007).
213 Id. at No. 7-10.
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Civil Code and thus cannot be equated with a manual signature. 21 4 Only
qualified electronic signatures and accredited qualified electronic
signatures fulfill the requirements set by the Signature Act.215 Qualified
electronic signatures under section 2 No. 3 Signature Act at the time of
their creation are based on a valid qualified certificate and are
generated with a secure signature creation unit. This is the key
difference between qualified electronic signatures and simple or
advanced electronic signatures. The qualified electronic signature
implies that the signature key is saved to a non-readable hardware unit.
Because of the high technological standard, the law equates the
qualified electronic signature with the manual signature. Thus, all
natural persons are entitled to submit a request for a qualified electronic
signature, unlike corporations or public administration entities. Under
section 7 (1) No. 1 Signature Act, a qualified certificate must contain
the name of the owner of the key, the assigned signature key, the
algorithms, the serial number of the certificate and the beginning and
end of the validity of the certificate. The information of section 7 (1)
No. 7 Signature Act is of special interest, as the certificate can also
contain information regarding the limit of use of the signature key.
Under section 15 (1) Signature Act, there is a "proven" security
associated with accredited qualified electronic signatures. All products,
components, and the entire procedure of electronic signatures are tested
and affirmed by an independent entity pursuant to section 18 Signature
Act (e.g., TUV Informationstechnik GmbH). The inspection and
authentication is not only verified by the cachet designating the
accredited certification center. Rather, the cachet provides proof of the
comprehensively inspected technical and administrative safety. 216 Only
the certification services for accredited electronic signatures have so-
called root certificates issued by the Federal Network Agency
(Bundesnetzagentur) (section 16 Signature Act). Through these
certificates, not only the membership certificates of users but also the
certificate of the certification service can be verified. Only such
verification leads to certainty that the certificate service provider who
issued the user certificate indeed exists. Thus, the difference between a
qualified electronic signature and an accredited qualified electronic
214 Id. at No. 85.
2
' Id. at No. 86.
216 Id. at No. 97-98; Ivo Geis, Die elektronische Signatur: Eine
internationale Architektur der Identifizierung von E-Commerce, 3
MULTIMEDIA UND RECHT [MMR], 667, 670 (2000).
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signature (with cachet) lies in the technical safety check.217 The
certificate service providers offering qualified electronic signatures
compile a security concept outlining in detail the maintenance of the
safety requirements. The decisive factor, however, is that the
technologies employed are not tested and approved by an independent
expert entity. An exception exists for the chip card as a secure signature
generating unit and carrier of the secret signature key. It must be
approved with regard to its safety by a testing and approval entity. For
all other products, a declaration of the manufacturer is sufficient
(section 17 (4) Signature Act in connection with section 15(5)SigV-E).
In the declaration, issuer and product have to be specifically designated
and specific statements have to be made as to the provisions of the
Signature Act and the Signature Regulation that are fulfilled; thus, one
speaks of "asserted security." The certification service provider has to
keep the certificates for the duration of their validity plus five years.
The qualified electronic signatures are only verifiable for this period of
time. Should the certification provider become bankrupt in the
meantime, the time span may be even shorter. When signatures are no
longer verifiable, they become worthless as evidence.218
B. Electronic Documents as Evidence
Using electronically signed documents raises the question of
their evidence quality. Electronic documents can be submitted as
evidence pursuant to section 371(2) of the Federal Code of Civil
Procedure (Zivilprozessordnung, ZPO). The value of the submitted
evidence is governed by the concept of the judge's free consideration of
evidence (freie Beweiswiirdigung) under section 286 of the Federal
Code of Civil Procedure. Central aspects to be considered are the
integrity of the contents and the authenticity of the producer of an
electronic document. However, since electronic documents can be
easily manipulated, integrity and authenticity may be hard to prove. In
civil proceedings, producing a deed as evidence has exceptional
importance as the court is bound to the content of the deed pursuant to
section 416 of the Federal Code of Civil Procedure. Documents only
have deed quality if they contain an individual's thought in written
form and are signed by the issuer. Electronic documents can take
217 Brisch & Brisch, supra note 212, at No. 92.
218Alexander RoBnagel, Das neue Signaturgesetz - Grundlage des
elektronischen Rechtsverkehrs, 4 MULTIMEDIA UND RECHT [MMR] 201, 202
(2001); Brisch & Brisch, supra note 212, at No. 96.
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several forms: they can be saved to a storage device, they can be
visualized on a monitor, or a printout can be presented. The problem is,
however, that neither form of the electronic document contains a
signature conforming to section 126 of the Civil Code so that they are
not of deed quality. If the electronic document in all its forms does not
have the quality of a deed, the court is not bound to the contents of the
document pursuant to section 416 of the Federal Code of Civil
Procedure.
2 19
The evidence quality of electronically signed documents
depends on the quality of the electronic signature. Only the qualified
electronic signature of an accredited certificate provider reaches the
highest evidence quality. The Judicial Communication Act
(Justizkommunikationsgesetz) of 2004220 documents the intention to
support the use of electronic signatures. It grants qualified electronic
signatures the highest evidence quality. The deed provisions are to be
applied pursuant to section 371a (1) of the Federal Code of Civil
Procedure to private electronic documents. Moreover, they are awarded
the appearance of authenticity under section 371a. Thus, the private
electronic document is equal in quality to the public electronic
document with qualified electronic signature, which also enjoys the
presumption of authenticity, section 371a (2)(2) and section 437 of the
Federal Code of Civil Procedure. The deficit of electronic documents
with qualified electronic signatures in the area of evidence as opposed
to deeds has been eliminated.
C. Electronic Signatures and E-Health
In the area of electronic signatures, e-health programs pose
specific challenges. In the U.S. context, the need for a federal standard
for electronic signatures in e-health was raised as a key concern. 22 1 The
e-prescription, for example, is intended to be included in the German
219 Ivo Geis, Beweisqualitdt eletronischer Dokumente, passim, in HANDBUCH
MULTIMEDIARECHT, supra note 212; Klaus Oertel, Elektronische Form und notarielle
Aufgaben im elektronischen Rechtsverkehr, 4 MULTIMEDIA uND RECHT [MMR] 419
(2001); Michael Schmidl, Die elektronische Signatur. Funktionsweise, rechtliche
Implikationen, Auswirkungen der EG-Richtlinie, 18 COMPUTER UND RECHT [CR] 508,
517 (2002).
220 Gesetz tber die Verwendung elektronischer Kommunikationsformen in der Justiz
(Law on the use of electronic communication forms in the judiciary) of October 28,
2004, BT-Drucksache 15/4067.
221 Ashoke S. Talukdar, Electronic Signatures in E-Healthcare: The Need for a
Federal Standard, 18 J.L. & HEALTH 95, 103-04 (2003/2004).
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pilot projects and is based on the electronic signature. In this context,
the procedure of attaching an electronic signature has been criticized as
too complicated, since first, the electronic health card of the insured
patient is inserted into the card reader, followed by the electronic health
professional ID card of the physician. Then, the physician has to enter
the six-digit PIN.222 It has been asserted that this procedure takes
twelve times longer than manually signing the prescription: according
to one study it took a physician only two seconds to manually sign a
prescription while entering a six digit PIN took about 24 seconds. 223 Of
course, this is not the most serious problem concerning digital
signatures in the area of health care. It does, however, illustrate an
example of the importance of acceptance of the new initiatives in the
realm of the key players. Here, a parallel to data security and protection
issues - subjective acceptance of the new technology as a prerequisite
for its successful implementation - can be drawn.
The use of the electronic signature further becomes relevant in
the context of electronic storage of medical documentation. Medical
documentation is primarily necessary for patient care, but also for
administrative tasks, research and teaching, and quality management.
224
While one objective of medical documentation is making available
medical knowledge in order to prevent, diagnose, and efficiently treat
diseases, the primary goal is the support of the medical treatment of
patients. In order to ensure that the relevant information is available at
the right time, in the right place, and in the right form, documentation
systems have to meet high standards. 2
25
1. Electronic Health Card and E-Prescription
The electronic signature and encoding are especially relevant in
connection with the electronic health card. The Card is a central
component of the future structure of German health care. Data safety
issues are especially relevant because of multiple interactions with
peripheral systems, in contrast to the electronic ID card, for example.
The sensitive data should therefore not be transmitted via the internet
but rather via virtual private networks (VPNs). Encoding the data
stored on servers can avoid or at least hinder others from accessing the
222 Klaus Schmidt, Biirokratie- und Kostenschub in der Praxis, 32 NOTFALL &
HAUSARZTMEDIZiN 567 (2006).
223 Id.
224 Brandner, supra note 208, at 9.
2251Id. at 15.
2009]
DEPAUL JOURNAL OF HEALTH CARE LAW
226data. As already mentioned, the electronic prescription (e-
prescription) is intended to be a key application of the health card. The
physician creates a prescription, signs and encodes it, and transmits it to
a pharmacy. The pharmacy then transmits the data to a central entity
which in turn transmits it to the health insurance. 227 The e-prescription
is stored independent of the intent of the insured individual. The
legislature has not decided whether storage will take place on a server
or on the card. Thus, there is no legislative basis for allowing a data
transfer to external service providers. If storage takes place on the card
itself, there is no data transfer to external third parties. However, if data
is transmitted on a server, end-to-end encoding should be employed. In
this case, the prescription would be outfitted with the public key of the
health card. Thus, data transmission by third parties can be conducted
safely.2
28
2. Long-Term Storage of Medical Records
Another important application of the electronic signature in the
area of e-Health concerns medical records. In fact, long term storage of
electronically signed documents has been identified as one of the key
challenges in the e-health area.229 Different laws and regulations
demand that medical records and documentation be kept for differently
long periods of time.230 One of these regulations is the Model
Professional Code of Conduct for Physicians (Musterberufsordnungfiir
Arzte, MBO-A). Under section 10 of the MBO-A, physicians are
obliged to keep records of their professional activities that are not only
considered an aid to their own memory, but also serve the interest of
the patients.23' Proper medical documentation in fact is a secondary
obligation following directly from the contract regarding medical
treatment. 232 Thus, the Federal Court of Justice (Bundesgerichtshof
BGH) decided that maintaining proper documentation regarding the
226 Homung, supra note 81, at 363.
227 Volker Leienbach, Das elektronische Rezept aus Sicht der Privaten
Krankenversicherung, in EHEALTH, supra note 82, at 41, 43.
228 Homung, supra note 92, at 290-291.
229 Id. at 366.
230 Brandner, supra note 208, at 9. See also PAUL SCHMUCKER, ARCHIVIERUNG UND
PRASENTATION VON HETEROGENEN KLINISCHEN OBJEKTEN IN ELEKTRONISCHEN
PATIENTENAKTEN 68 (1998) (for an overview of medical documentation and medical
record storage requirements).
231 Brandner, supra note 208, at 16.
232 Id. at 16; Kilian, supra note 106, at 2316; Hornung, supra note 92, at 59.
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patient is an obligation of the physician. 233 Further documentation
obligations follow from other statutes. Under Article 1 of the Health
Structure Act (Gesundheitsstrukturgesetz) of 1992, physicians and
medical care providers are obliged to transmit diagnoses and a
description of the services rendered to the health insurances. Hospitals
also have to provide the day and time of admission and the
identification number of the referring physician. Other provisions
demanding documentation are, for example, section 43 Radiation
Protection Regulation (Strahlenschutzverordnung) , section 29 X-Ray
Regulation (Rdntgenverordnung), section 19 of the Regulation on
hazardous industrial materials (Arbeitsstoffverordnung), section 37 of
the Youth Employment Protection Act (Jugendarbeitsschutzgesetz).234
The Model Code of Professional Conduct states that medical
documentation must be kept for at least ten years while other provisions
contain a thirty year requirement, such as section 28 No. 4 (1) X-Ray
Regulation, section 42 (3) Radiation Protection Regulation, section 14
(3) Transfusion Act (Transfusionsgesetz), section 15 (2)
Transplantation Act (Transplantationsgesetz, TPG). In relation to data
protection, it may be worth pointing out that these documentation
provisions demand continued storage of data without the patient's
consent as to specific data or without the patient's ability to have
certain data deleted, as otherwise the rule in data protection law. The
documentation, however, is to be limited to the data the insured
individual has disclosed voluntarily.
2 3 5
Hospital archives, however, are reaching their capacities due to
the volume of paper-based patient records and the long time periods for
which they have to be kept. Further problems with traditional archives
include long searches, limited hours of operation, incomplete or lost
records, and the general problem of diverging organization criteria.
236
Thus, while electronic archives as a general matter appear to be a
favorable solution to the problem of hospital documentation
requirements, they, too, contain specific potential hazards. This
particularly concerns the long-term safety of electronically signed
archives which in the e-Health context not only include hospital
archives but also archives of health insurances. Especially in the case of
233 Federal Court of Justice [Bundesgerichtshof][BGH] June 27, 1978, 31 NEUE
JURISTISCHE WOCHENSCHRIFT [NJW] 2337, 2338-2339 (1978).
234 Brandner, supra note 208, at 17.
235 Hornung, supra note 92, at 60.
236 Brandner, supra note 208, at 19.
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archives with great volumes of data, solutions regarding potentially
decreasing security have to be found.237
The algorithm used for creating the electronic signature can lose
its security due to new scientific insights or technical advances.
Electronically signed documents, in turn, lose certain properties with
the decline of the signature security. Most importantly, they can lose
their evidence quality.238 Thus, the Federal Network Agency is
discontinuing the validity of certificate key lengths of 1024 bit by the
end of 2007 and changing instead to a bit length of 2048 bit. For many
documents, a qualified electronic signature is a prerequisite for their
validity, as expressed in section 126a of the Civil Code. If, after long
periods of time, it is disputed that the original signature was a qualified
electronic signature, it has to be proven that the signature did in fact
have this quality. This problem specifically concerns the security of the
public key. It may become possible over time, with advances in
cryptoanalysis and increased computer capacities to calculate a secret
key.
239
This results in the necessity to renew the electronic signatures
used in digital archives. The statutory basis is found in section 6
Signature Act and section 17 of the Signature Regulation
(Signaturverordnung, SigV). Under section 6 of the Signature Act, the
certification center has to inform the applicant that data with electronic
signatures have to be signed again if necessary, before the security of
the existing signature decreases. This, however, does not lead to an
obligation of the applicant to follow the recommendations of the
certification center. Rather, it is the sole responsibility of the applicant
to take the necessary steps ensuring data safety. The necessary security
measures are to be qualified as obligations. 240 The omission to take
necessary safety measures does not have any consequences for the
attribution of the digital signature. 24 1 This is confirmed by the evidence
rules regarding electronic documents. Under section 371a (1)(2) of the
237 Alexander RoBnagel, Stefanie Fischer-Dieskau, Ulrich Pordesch & Ralf Brandner,
Erneuerung elektronischer Signaturen, 19 COMPUTER UND RECHT [CR] 301 (2003).
238 Brandner, supra note 208, at 79. See also legislative materials (Begrtindung zum
Entwurf einer Verordnung zur elektronischen Signatur in der Fassung des
Kabinettsbeschluss vom 24.10.2001, zu § 17, S. 34).
239 Willi Geiselmann, Jm Mfiller-Quade, Rainer Steinwanndt, Ober
Quantencomputer und Quantenkryptographie, 26 DATENSCHUTZ UND
DATENSICHERHEIT [DUD] 453 (2002).
240 Legislative materials § 5 Abs. 2 S. 2 des Art. 2 des 1. Referentenentwurfs zum
IuKDG of June 28, 1996
241 RoBnagel, supra note 209, at § 6 No. 38.
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Federal Code of Civil Procedure, the appearance of authenticity of a
declaration in electronic form can only be destroyed if there are serious
doubts that the declaration was given by the owner of the signature key.
If the key owner asserts that the renewed signature was forgotten,
however, no serious doubts arise that the original electronically signed
document originated from the key owner. The content of the document
is assigned to the key owner. It is important to note, however, that
neglecting to perform the necessary safety measures does lead to the
loss of the appearance of security. 242 In order to preserve the original
evidence quality of electronic archives and document management
systems, a new signature has to be created. The existing signatures are
encompassed by the new signatures and thus conserved. It is irrelevant
who produces the new signature so that it can be produced by an
archivist. 243 This is possible because no individual will is expressed in
attaching the new signature; rather it expresses that the intended
security function be fulfilled.2 44 Section 17 Signature Regulation
determines the procedure for long-term data security by use of re-
signing the documents with qualified electronic signatures if they are
needed for longer periods of time. Prior to the expiration of the security
of the algorithms or the respective parameters, the documents are to be
outfitted with a new qualified electronic signature. This has to be done
with new algorithms or parameters and include prior signatures.
Moreover, the re-signature has to include a qualified time stamp. Thus,
by conserving the original signature, its original form can be proven.
245
IV. ONLINE PHARMACIES
While both European and German initiatives are intended to
further the advancement of e-health, some elements are bound to clash
with existing laws. Although the use of information technology is
generally supported, some areas are still regulated by concepts
predating the intended large-scale introduction of information
technology in healthcare. One such example is provided in the
following section which outlines and examines the German legal
struggles involving the online pharmacy DocMorris, culminating in
242 Id. at No.39
243 RoBnagel et al, supra note 237, at 302 (citing BR-Drucksache 966/96, 29).
244 Id. at No. 303.
245 Alexander RoBnagel & Ulrich Pordesch, Signaturverordnung, § 17 No. 5 in
RECHTE DER MULTIMEDIA-DIENSTE, supra note 209.
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decision of the European Court of Justice (ECJ) in December 2003.246
Another question, concerning the online distribution of drugs subject to
licensing in Germany but not subject to licensing elsewhere in the EU,
was answered by the German Federal Court of Justice (BGH) in
2472006. Even after these decisions, there continue to be legal
uncertainties regarding the status of online pharmacies. Especially
DocMorris has a continued presence in the legal discussions.
A. The DocMorris Decision of the ECJ
0800 DocMorris NV is a limited company established in the
Netherlands. In addition to its physical pharmacy presence in
Landgraaf, Netherlands, it conducts an online business. Both the
pharmacy and the website are covered by a Dutch license.2 48 Also
named as a defendant in the original lawsuit was Mr. Waterval, an
authorized pharmacist who until May 30, 2001, was a director of
DocMorris. 24 9 Since 2000, DocMorris had been offering prescription
and non-prescription drugs on its website in different languages,
including German, targeting end consumers in Germany. Only
authorized drugs were sold, some of which were authorized in
Germany and others in the Netherlands. °
On the DocMorris website, the individual drugs were divided
into product groups. Following a brief introduction, the drugs were then
listed in alphabetical order under their product name with a description
of the content and the price in Euro. Further information about the
product could be obtained by clicking on the product name.
251
Prescription requirements were noted next to the product description. A
given drug was classified as a prescription only drug either if it was
available on prescription in the Netherlands or in the customer's
country of residence. If the prescription status differed in the
Netherlands and the country of residence, the stricter rule applied.
Prescription drugs were only supplied upon submission of the original
prescription. 252 By clicking on the appropriate icon, the customer could
246 ECJ Case C-322/01, available online at www.curia.europa.eu [hereinafter:
DocMorris decision]
247 Federal Court of Justice [Bundesgerichtshof][BGH] decision of Mar 30, 2006,
docket no. I ZR 24/03, 9 MULTIMEDIA UND RECHT [MMR] 461 (2006).
248 DocMorris decision, supra note 246, at para. 35.
249 Id.
2 50 Id. at 36.
251 Id. at 37.
52 Id. at 38.
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also look for a particular product from the range offered and consult a
group of experts on health issues. DocMorris could be contacted by
consumers either via the internet or on a toll-free phone number or by
253mail. Pickup of the order could take place either in person at the
physical presence of the pharmacy at Landgraaf, a town close to the
German-Dutch border, or the order could be delivered by courier, either
by a service of the defendant's choice at no additional cost or by
service of the customers' choice, at their own expense. 254
Several lawsuits against DocMorris were filed in Germany.255
The lawsuit leading to the ECJ judgment was brought before the
256Regional Court of Frankfurt (Landgericht Frankfurt am Main).
Plaintiff was an association representing the interests of German
pharmacies whose members are the federations and associations of
pharmacists at the state (Ldnder) level.257 The plaintiff argued that the
provisions of the Law on Medicinal Products (AMG) and the Law on
Advertising of Medicinal Products (HWG) do not permit the defendants
to engage in such a business, and the prohibition imposed by those two
laws cannot be challenged as violating supranational law on the basis of
Article 28 EC and 30 EC.25 8 The Frankfurt court expressed doubt
whether the prohibitions of section 43(1) and 73(1) of the Law on
Medicinal Products violated the free movement of goods. Assuming an
infringement on Article 28 EC, the court then asked whether the
German legislation is necessary to effectively protect the health and life
of humans for purposes of Article 30 EC or whether in light of the
increasing harmonization of procedures for authorizing medicinal
products, human health and life may be protected as effectively by less
restrictive measures. Finally, it asked whether advertising bans such as
those imposed by the Law on Advertising of Medicinal Products are
compatible with the principles of the free movement of goods and the
free movement of information society services within the meaning of
Article 1(1) and (2) of the directive on electronic commerce. 259 Due to
these questions concerning Community law, the Frankfurt court stayed
253 Id. at 39.
254 Id. at 40.
255 E.g., LG Frankfurt a.M. and OLG Frankfurt a.M., 1 GEWERBLICHER
RECHTSSCHUTZ UND URHEBERRECHT RECHTSPRECHUNGS-REPORT [GRUR-RR] 244
(2001).
256 DocMorris decision, supra note 246, at 41.
257 Id. at 34.
258 Id. at 41.259Id. at 43.
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its proceedings and referred three questions to the ECJ for a
preliminary ruling.26 °
Indicating its exceptional importance, the case was referred to
the full court pursuant to Article 16(5) of the ECJ Statute.2 6 1 Important
new developments were expected in the area of the free movement of
goods. In fact, it was asserted that DocMorris promised to join the
group of landmark cases in the area of the free movement of goods,
such as the Dassonville,262 Cassis de Dijon,263 and Keck 264 decisions. 265
The decision in fact did elaborate on the content and scope of the Keck
formula, and the ECJ - albeit silently - diverged from its prior
jurisprudence. 266
The questions presented to the ECJ concerned the interpretation
of Article 28 and Article 30 EC on the advertising of medical products
for human use, in conjunction with Directive 200/31/EC of the
European Parliament and of the Council of June 8, 2000, on certain
legal aspects of information society services, in particular electronic
commerce, in the internal market (the Directive on electronic
commerce). 26 ' A preliminary judgment of the ECJ was sought
concerning three questions.26 The Court answered the first question
regarding the free movement of goods, and the second question of
advertising. The third question, which concerned a follow-up question
on advertising, namely whether despite an infringement on advertising
regulations the cross-border trade was lawful,269 was not answered by
the Court in light of its answer to the second question.
270
260 Id. at 44.
261 Christofer Lenz, Warenverkehrsfreiheit nach der DocMorris-Entscheidung zum
Versand von Arzneimitteln, 57 NEUE JURISTISCHE WOCHENSCHRIFT [NJW] 332
(2004).
262 Case, 8-74, Procurer du Roi v. Benoit, 1974 E.C.R. 837
263 Case 120-78, Rewe-Zentral v. Bundesmonopolverwaltung fir Branntwein, 1979
E.C.R.
264 Cases C-267/91 and C-268/91, Criminal Proceedings against Bernard Keck and
Daniel Mithouard, 1993 E.C.R. 6097.
265 Lenz, supra note 261.
266 Benjamin Koch, Eine erste Bewertung der Entscheidung "DoeMorris" des EuGH,
15 EUROPAISCHE ZEITSCHRIFT FUR WIRTSCHAFTSRECHT [EuZW] 50 (2004).
267 DocMorris decision, supra note 246, at 1.
2681 d. at 44.
269 Id.
270 Id. at 150.
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1. Free Movement of Goods
The first question raised the issue of the free movement of
goods under Articles 28 EC and 30 EC. It asked whether national
legislation restricting the sale of drugs to pharmacies in the Members
State and prohibiting the commercial import via mail order in response
to individual orders placed by consumers over the internet through
pharmacies approved in other Member States violates the free
movement of goods. 27' The ECJ first examined drugs not authorized in
Germany, then drugs authorized in Germany. Regarding authorized
drugs, the Court distinguished between prescription drugs and non-
prescription drugs.
27 2
Regarding drugs not authorized in Germany, section 73(1) Law
on Medicinal Products generally prohibits the import. The prohibition
is based on the lack of authorization or registration for the German
market. Thus, their import is not permitted irrespective of the mode of
sale.273 The Court found that section 73(1) Law on Medicinal Products
complies with community law. In fact, the prohibition corresponds to a
prohibition at the Community level, formerly Article 3 of Directive
65/65, now replaced by Article 6(1) of the Community Code. 274 If
pharmaceuticals are to be placed on the market in a Member State, they
have to be authorized by the competent authority of that state or under
community rules, even if they are already authorized in another
Member State.2 75 This finding certainly was the least surprising aspect
of the decision.276
Turning to drugs authorized for sale in pharmacies Germany,
the Court presents the question as whether the prohibition on the mail-
order sale of drugs which in the Member State are only sold in
pharmacies violates the free movement of goods. 277 It breaks the
question down into three parts, namely first, whether the national
prohibition on mail-order sales is a measure of equivalent effect, 27
8
second, whether the prohibition can be justified (here, the Court
271 Id. at 45.
272 Id. at 46.
273 Id. at 47.
274 Id. at 52.
275 Id.
276 Elmar Mand, Anmerkung, 7 MULTIMEDIA UND RECHT [MMR] 155 (2004).
277 DocMorris decision, supra note 235, at 55.
278 Id. at 55 et seq.
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distinguishes between prescription and non-prescription drugs), 279 and
third, the question of reimport of drugs.280
Under Dassonville, all measures capable of hindering intra-
Community trade directly or indirectly, actually or potentially, are
regarded as measures having equivalent effect to quantitative
restrictions. As such, they are prohibited under Article 28 EC.2 8 1 If a
measure is not intended to regulate trade between Member States, the
determining factor is its actual effect. Thus, obstacles to the free
movement stemming from the imposition of requirements on goods
coming from other Member States where they are lawfully
manufactured and marketed constitute measures of equivalent effect
even if the rules apply to all products alike. Such restrictions are
prohibited by Article 28 EC. However, as the Court held in Cassis de
Don and Keck, such restrictions are permissible if they can be justified
by a public interest objective that outweighs the requirement of the free
movement of goods.2  Under Keck, even if commercial rules do not
relate to the actual characteristics of the products but only govern sale
arrangements, they may constitute measures of equivalent effect under
Article 28 EC. In order to pass Article 28 EC muster, the rules must
meet two conditions: (1) The rules must apply to all relevant traders
operating in national territory and, (2) they must, in law and in fact,
affect the marketing of domestic products and those from other
Member States in the same manner.
283
The Court finds that section 43(1) of the Law on Medicinal
Products applies equally to all traders so that the first requirement of
the Keck standard is met. Section 43(1) Law on Medicinal Products,
however, fails to meet the second Keck requirement. The prohibition
contains a requirement that certain medicines be sold only in
pharmacies as wells as a prohibition on drug mail-order sales. The
latter may be regarded as a mere consequence of the former. However,
in the Court's view, the emergence of the internet as a method of cross-
border sales requires a broad-scale look at the scope and the effect of
the prohibition. Section 43(1) Law on Medicinal Products poses a
greater obstacle to pharmacies outside of Germany than to those in
Germany. Even though pharmacies in Germany may not use mail-order
279 Id. at T 77 et seq.
280Id. at 125 et seq.
281 Id. at 66.282 Id. at 67.2831 d. at 68.
284 Id. at 73.
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sales as an additional or alternative method of gaining access to the
German market, they are still able to sell the products at their physical
locations. For pharmacies not established in Germany, on the other
hand, the internet provides a more significant way to gain direct access
to the German market. Thus, the impact of the provision is greater on
pharmacies outside of Germany as their market access is hindered more
significantly than German pharmacies' market access.2 85 As a result,
the Court finds that the prohibition on mail-order pursuant to section
43(1) of the Law on Medicinal Products is a measure having an effect
286
equivalent to a quantitative restriction under Article 28 EC.
Turning to the justification of section 43(1), the Court looks at
Article 30 EC. The Court points out that Article 30 continues to apply
to the manufacture and marketing of drugs absent full harmonization of
national rules. With regard to the sale of drugs to consumers, the Court
states that there is no full Community harmonization.287 Health and life
of humans are the foremost interests protected by Article 30 and, within
the limits of the Treaty, Member States can decide on the level of
protection. 28 As national rules will have a restrictive effect, however,
only such national rules are permissible that are necessary for the
effective protection of health and life of humans. National rules do
meet the standard "if the health and life of humans may be protected
just as effectively by measures which are less restrictive of intra-
Community trade. ' 28Y Before analyzing the rules under the standard,
the Court points out that the virtual pharmacy is subject to supervision
by the Dutch authorities. 290 Further, it points out the arguments that
may justify the prohibition of mail order: the need to provide individual
advice to the customer, the ability to check if prescriptions are genuine,
and guaranteeing the wide availability of drugs.
291
The Court proceeds by distinguishing between non-prescription
and prescription drugs. It finds that regarding the former, there are no
reasons justifying the prohibition.292 Prescription drugs, however, need
to be more strictly controlled.293 Therefore, it finds that "the need to be
able to check effectively and responsibly the authenticity of doctors'
285 Id. at 74.
286 Id. at 76.
287 Id. at 102.
288 Id. at 103.
289 Id. at 104.
29
' Id. at 105.
29 Id. at 106.
292 Id. at 112-116.
293 Id. at 117.
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prescriptions and to ensure that the medicine is handed over either to
the customer himself, or to a person whom its collection has been
entrusted by the customer, is such as to justify a prohibition on mail-
order sales." 294 The Court then turns to the issue of drug prices which,
in its view, would support the prohibition, but which was not
submitted.295 Overall, the Court thus finds that while a prohibition on
mail order cannot be justified under Article 30 for non-prescription
drugs, the prohibition on prescription drugs is justified.296 The question
of reimport of prescription drugs does not change the Court's prior
assessment.297
Overall, thus, the ECJ asserted a relatively comprehensive
ability of the Member States to restrict drug mail order businesses in
the interest of consumer protection. Only general national prohibitions
for the mail order of non-prescription drugs were found to be
incompatible with community law. However, regulatory provisions for
consumer protection still remain possible in this area as well.298
2. Advertising
The Court identifies three prohibitions on advertising. First,
under section 3 Law on Advertising of Medicinal Products, a
prohibition on advertising of drugs subject to authorization for which
authorization has not been obtained. As this prohibition corresponds to
a provision in community law, the Court does not further examine the
national regulation. 299 Second, section 10(1) Law on Advertising of
Medicinal Products prohibits generally advertising for prescription
drugs. Since this provision implements a harmonization measure of the
Community, this provision, too, requires no further consideration.
30 0
Third, section 8(1) Law on Advertising of Medicinal Products prohibits
advertising mail order sales of drugs which may only be sold in
294 Id. at 119.
295 Id. at 122-123. Here the Court states that "a national market for prescription
medicines could be characterized by non-commercial factors, with the result that
national legislation fixing the prices at which certain medicinal products are sold
should, in so far as it forms an integral part of the national health system, be
maintained." Id. at 122.296 Id. at 124.
297 Id. at 134.
298 Mand, supra note 276, at 158.
299 DocMorris decision, supra note 246, at 138.
300 Id. at 139.
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pharmacies. 3° 1 There is no corresponding provision in Community law,
the Court states. 302 Again, the Court distinguishes between prescription
and non-prescription drugs, holding that while "Community law does
not preclude a prohibition on mail-order selling of prescription
medicines' '30 3 it does preclude a national prohibition on advertising the
mail order sale of drugs only sold in pharmacies in the Member State if
the drugs can be bought without a prescription.
30 4
3. Assessment and Legislative Changes
Unsurprisingly, assessments of the decision varied. On the one
hand, it was pointed out that the impact of the decision would be
relatively small, mainly because profoundly divergent rules regarding
prescription requirements exist in the Member States. These differences
pose a significant obstacle to transnational commerce with prescription
drugs. It was pointed out though that perhaps the decision would be a
stepping stone for a further harmonization of the rules regarding
prescription requirements for drugs and for the operation of
pharmacies. 30 5 On the other hand, however, it was asserted that the
decision is highly important beyond the scope of the pharmaceuticals
sector as it contained a modification to the Keck rule, imposing more
306burdens on the Member States. Moreover, the ECJ itself engaged in
an examination of the neutrality principle and imposed the burden of
proof regarding the neutrality of the effect on the Member States. As
far as the justification level is concerned, it has been observed that the
ECJ is moving further away from a German-style proportionality
analysis and instead seeks the solution in the ever-growing area of
secondary Community legislation. From secondary legislation, the ECJ
distills value judgments that in turn influence its decisions regarding
necessity and adequacy in its justification analysis. Claims have been
made that this practice makes decisions of the ECJ in the area of the
free movement of goods even harder to predict. 307
The effect of the decision was limited in Germany. In 2004, the
ban on all mail order sales of medicines, including prescription drugs,
301 Id. at 140.
3021 d. at 141.
303 Id. at 147.
304 Id. at 148.
305 Mand, supra note 276, at 158.
306 Lenz, supra note 261, at 334.
307 Id.
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was lifted in the Statutory Healthcare Modernization Act. The
permissibility is contingent on obtaining a mail-order license. However,
the extent of the new regulation undermines the arguments made before
the ECJ concerning prescription drugs.3 °8 The resulting legislative
change thus goes beyond what the ECJ required. 30 9 The ongoing
DocMorris proceedings before the ECJ may have been helpful in
finding a consensus among Germany's government and opposition
parties regarding a change in the law permitting drug mail orders. As a
result, Germany proceeded to widely liberalize the mail order of
drugs.31
0
B. Continued Legal Battles
Following the ECJ decision, legal disputes over issues
connected with online pharmacies continued. The Federal Court of
Justice decided in March 2006 that a prohibition on the sale of drugs
subject to licensing in Germany but not in other EU Member States is
permissible. 3 1  The important decision extends far beyond the
immediate area of drug mail order. It has, in fact, been called a
milestone in the law of online marketing. 31 2 A Dutch company offered
on its website various products for medicinal purposes (e.g., garlic and
St. John's wort capsules). The website contained a disclaimer stating
"German speaking Europeans, but not to German addresses". 31 3 A key
aspect of the decision concerned conflict of laws issues. The Federal
Court of Justice found that a website is subject to German competition
law if the content has an intended effect in Germany. 314 Disclaimers
may be used to exclude these effects, but they have to be genuine. In
this case, the disclaimer was held to be not genuine as deliveries to
Germany were in fact made.315 The country of origin principle, which
requires compliance only with the laws of the country of origin, does
not apply since national regulations regarding the protection of health
308 Rudolf Streinz, Freier Warenverkehr - Grenziberschreitende Tdtigkeit von
Apotheken - DocMorris, 44 JURISTISCHE SCHULUNG [JuS] 518, 521 (2004); Koch,
supra note 266, at 51.
309 Streinz, supra note 308, at 521.
310 Mand, supra note 276, at 158.
311 Federal Court of Justice, supra note 247, at 461.
312 Thomas Hoeren, Anmerkung, 9 MULTIMEDIA UND RECHT [MMR] 464 (2006).
313 Federal Court of Justice, supra note 247, at 461-462.
314 Id. at 463.
315 id
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can be imposed by national law.316 In the case of medicinal products
not authorized domestically, the Court referred to the Community laws
expressly permitting prohibitions for advertising of non-authorized
drugs.
317
On a different front, DocMorris is currently involved in
litigation concerning the permissibility of pharmacy ownership by a
capital corporation (in this case, a Dutch stock corporation). Although
this aspect is not directly related to DocMorris's e-commerce activities,
it illustrates the difficulties of harmonizing the EU health market in
exemplary fashion. The facts are simple yet perhaps - knowing drug
store giants such as CVS or Rite Aid with integrated pharmacies -
somewhat perplexing from an outside perspective. DocMorris bought a
pharmacy in the German state of Saarland and employed as the
responsible pharmacist the former owner, a licensed pharmacist.
318
Even after the most recent legislative changes, the individual
pharmacist in his own pharmacy, as described in the famous Pharmacy
decision (Apothekenurteil) of the Federal Constitutional Court,319 is
still the guiding legislative principle in Germany while in other
Member States of the EU corporations may own pharmacies. 31 Capital
corporations (such as a GmbH or AG) cannot obtain licenses for
pharmacies (section 8 of the Pharmacy Act, Apothekengesetz).
Although the district court (Landgericht) of Saarbrficken in
August 2006 rejected the challenge of another pharmacist on unfair
competition grounds,321  the Saarlouis Administrative Court in
September 2006 ruled that a store operated by DocMorris had to
close.322 On appeal, the State Administrative Court reversed.323 The
prohibition of outside ownership constitutes a limit on the freedom of
316 id.
311 Id. at 463-464.
318 See, e.g., Wolfgang Semmroth, DocMorris als Einfalltor fir
Normenverwerfungskompetenz der Verwaltung? 25 NEUE ZEITSCHRIFT FOR
VERWALTUNGSRECHT [NVwZ] 1378 (2006).
319 Federal Constitutional Court [Bundesverfassungsgericht][BVerfG] decision of
June 11, 1958, 17 ENTSCHEIDUNGEN DES BUNDESVERFASSUNGSGERICHTS [BVerfGE]
232 (240). The decision is famous because the Court articulated its Three Step Theory
(Dreistufentheorie) as the doctrinal basis for Article 12 freedom of occupation.
320 Koch, supra note 266, at 51.
321 District Court [Landgericht] Saarbrticken, Aug. 9, 2006, docket no. 7 1O 06. See
also Senmroth, supra note 318 , at 1379 (discussing the case).
322 Administrative Court [Verwaltungsgericht] Saarlouis, decision of Sept. 13, 2006,
docket nos. 3 F 38/06 and 3 F 39/06.
323 State Administrative Court, decision of January 22, 2007, docket nos. 3 W 14/06
and 3 W 15/06.
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establishment pursuant to Articles 43, 48 EC. As such, it needs
justification. In order to be justified, it must be appropriate and
324necessary to further the intended goal.  At the center of attention is
the question whether the case is analogous to a case decided by the ECJ
involving opticians in Greece.325 In this decision, the Court held:
In this case, it is sufficient to note that the objective of
protecting public health upon which the Hellenic Republic
relies may be achieved by measures which are less
restrictive of the freedom of establishment both for natural
and legal persons, for example by requiring the presence of
qualified, salaried opticians or associates in each optician's
shop, rules concerning civil liability for the actions of
others, and rules requiring professional indemnity
insurance.
326
The state administrative court held that the same must apply to
pharmacies under the condition that there is no higher health risk
involved that would generally require a higher responsibility. Even if
higher health risks may exist, however, a licensed pharmacist has the
necessary qualification to avoid such potential risks. 327 The matter will
eventually be resolved by the ECJ as the Commission in 2006 initiated
proceedings against Austria, Italy and Spain because of similar
restrictions on pharmacy ownership. 328 Meanwhile, DocMorris has
become engaged in franchising operations. Several pharmacies now
operate under the DocMorris franchise while being owned by
individual pharmacists. DocMorris teamed up with a pharmacist in
order to sell non-prescription merchandise.329
324 See, e.g., Case C-140/03, Comm'n of the European Crnty's v. Hellenic Republic,
2005 E.C.R. 4 [hereinafter Greek opticians case]. See also, Tobias Kruis, Das
Leitbild des Apothekers in der (nicht notwendig eigenen) Apotheke, 18 EUROPAISCHE
ZEITSCHRIFT FUJR WIRTSCHAFTSRECHT [EuZW] 175, 177 (2007).
325 Greek opticians case, supra note 324.
326 Id. at 34.
327 Kruis, supra note 324, at 177.
328 Eberhard Eichenhofer, Auswirkungen europdischen Rechts auf das deutsche
Gesundheitswesen, 25 MEDIZINRECHT [MEDR] 329, 329-330 (2007).
329 Id. at 329.
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Healthcare reform remains at the top of the agenda, not only in
Germany but throughout Europe. The underlying factors in many of the
current disputes, such as in the DocMorris cases, are fundamental
questions of health policy. The potential of information technology
seemingly lends itself to offering new solutions and has been
discovered by lawmakers in the Member States as well as on the
supranational level. The EU is attempting to foster development of a
unified health market while the Member States assert their ultimate
competence in the area of national health policy. To a large extent,
though, they appear to be following the same goals as the supranational
initiatives. However, in both instances, appropriate regulation in the
healthcare area increasingly clashes with the ever accelerating speed of
technological advances. 330 Underlying the reform process, too, is a
change in the role of the state. Rather than "providing", it has been
suggested that the state should focus on "enabling".33 When
information technology meets healthcare, the legal ramifications have
to accommodate a rapidly changing and a highly regulated
environment. Striking a feasible balance, between regulation and
innovation as well as between national and supranational public health
policy, is the core challenge to the legal framework of e-health.
330 Marie-Theres Tinnefeld, Die Novellierung des BDSG im Zeichen des
Gemeinschafisrechts, 54 NEUE JURISTISCHE WOCHENSCHRIFT [NJW] 3078, 3078-
3079 (2001).
331 Id.
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